S0210569122001097 (3).pdf
- 1. 0210-5691/ © 2022 Elsevier España, S.L.U. y SEMICYUC. Todos los derechos reservados.
medicina intensiva
www.medintensiva.org
Medicina Intensiva 46S1 (2022):1-13
https://doi.org/ 10.1016/j.medin.2022.03.017
Volumen 34, Número 5. Junio-Julio 2010
Sociedad Española
de Medicina Intensiva, Crítica
y Unidades Coronarias
Federación Panamericana
e Ibérica de Sociedades
de Medicina Crítica
y Terapia Intensiva
www.elsevier.es/medintensiva
www.semicyuc.org
www.fepimcti.org
Incluida en:
Index Medicus/MEDLINE
EMBASE/Excerpta Medica
SCOPUS
ISSN:
0210-5691
Editorial
Diagnóstico precoz del fracaso renal agudo
M. Rodríguez López y A. Roglan Piqueras
291
Originales
Concordancia en pacientes críticos entre las
ecuaciones diseñadas para la estimación
del filtrado glomerular y el aclaramiento de
creatinina en orina de 24h
G. Seller-Pérez, M.E. Herrera-Gutiérrez,
E. Banderas-Bravo, R. Olalla-Sánchez,
R. Lozano-Sáez y G. Quesada-García
294
Sincronía auriculo-ventricular en pacientes
portadores de marcapasos con estimulación
VDD. Estudio descriptivo de un periodo de
14 años
A. Canabal Berlanga, M. Sánchez Casado,
J.M. Díaz Borrego, A. Raigal Caño y
P. Sánchez Rodríguez
303
Síndrome de Distrés Respiratorio Agudo,
durante la pandemia de Influenza A H1N1
2009 en Ecuador
G. Paredes y C. Cevallos
310
Puesta al día: El enfermo crítico con
infección grave
Neumonía asociada a la ventilación
mecánica
E. Diaz, L. Lorente, J. Valles y J. Rello
318
Debates en Medicina Intensiva:
Empleo de Descontaminación
Digestiva Selectiva
Pro descontaminación selectiva
M. Sánchez García
325
Descontaminación: un tratamiento sin
indicaciones
E. Palencia Herrejón y P. Rico Cepeda
334
Revisión
Hemofiltración de alto volumen en shock
séptico
C.M. Romero, P. Downey y G. Hernández
345
Nota clínica
Hiperinfección por Strongyloides stercoralis
J. Llagunes, E. Mateo, J.J. Peña, P. Carmona y
J. de Andrés
353
Cartas al Director
Administración accidental de dosis tóxicas
de adrenalina intravenosa a un lactante de
5 meses
M.S. Holanda Peña, J.L. Teja Barbero,
J. Velasco Montes y M. López Sánchez
357
Diagnóstico tardío de un caso de porfiria
aguda intermitente en una unidad de
cuidados intensivos
A.J. Betbesé, L. Zapata, C. Martínez-Brú y
C. Herrero
358
Muerte encefálica aparente tras sobredosis
de baclofén
R. Salas De Zayas, F. San José Pacheco,
C. Dolera Moreno y L. Zoila Peiró
359
Imágenes en Medicina Intensiva
Embolia aérea pulmonar como complicación
de punción venosa central
J. Bayón, M. Martín e I. Lozano
360
Actividad acreditada
en base a la encomienda de gestión concedida por los Ministerios
de Educación, Cultura y Deporte y de Sanidad y Consumo
ciales de Médicos con
2,1 créditos equivalentes a 10 horas lectivas.
www.formacion.elsevier.es/medicinaintensiva
COMISIÓN
DE FORMACIÓN
CONTINUADA DEL SNS
PALABRAS CLAVE
Sepsis;
Shock séptico;
Respuesta
LQÁDPDWRULD
Citocina;
Endotelio;
Endotoxina;
0LFURFLUFXODFLyQ
Resumen La sepsis y el shockVpSWLFRVRQHOUHVXOWDGRGHXQDUHVSXHVWDLQDGHFXDGDGHOKXpVSHG
DXQDLQIHFFLyQORTXHSURGXFHGLVIXQFLyQRUJiQLFD/DSURJUHVLyQGHHVWDDIHFFLyQVHPDQLÀHVWD
SRUODDSDULFLyQGHHVWDGLRVFOtQLFRVVXFHVLYRVGHULYDGRVGHODUHVSXHVWDLQÁDPDWRULDVLVWpPLFD
VHFXQGDULDDODDFWLYDFLyQGHGLIHUHQWHVPHGLDGRUHVLQÁDPDWRULRVTXHFRQGXFHQDODGLVIXQFLyQ
RUJiQLFD+DJUDQFDQWLGDGGHHYLGHQFLDVREUHHOSDSHOGHODHQGRWR[LQDHQODSDWRJpQHVLVGHOD
VHSVLVHOSDSHOIXQGDPHQWDOTXHWLHQHHQHOLQLFLRGHODUHVSXHVWDLQÁDPDWRULDHQODVHSVLVFDX-
VDGDSRUPLFURRUJDQLVPRV*UDPQHJDWLYRV/DDFWLYDFLyQGHODFDVFDGDGHFRDJXODFLyQHQORVSD-
FLHQWHVFRQVHSVLVHVSDUWHGHODUHVSXHVWDLQPXQLWDULDDGDSWDWLYDGHOKXpVSHGDODLQIHFFLyQ(O
HQGRWHOLRHVHOEODQFRSULQFLSDOHQODVHSVLVHOFXDOHVPHWDEyOLFDPHQWHDFWLYRSXHGHUHVSRQGHU
DGLYHUVRVHVWtPXORVÀVLROyJLFRVSDWROyJLFRV DFWLYDFLyQHQGRWHOLDO $GDSWDUORVWUDWDPLHQWRVD
SDFLHQWHVHVSHFtÀFRVHVXQDHVWUDWHJLDREOLJDGDSHUVRQDOL]DGDSDUDFHQWUDUVHHQODFRKHUHQFLD
KHPRGLQiPLFD/DLQYHVWLJDFLyQIXWXUDGHEHUHVSRQGHUDVLODVHVWUDWHJLDVGLULJLGDVDUHFOXWDU
PLFURFLUFXODFLyQSXHGHQPHMRUDUORVGHVHQODFHVFOtQLFRVGHORVSDFLHQWHV
‹(OVHYLHU(VSDxD6/86(0,87RGRVORVGHUHFKRVUHVHUYDGRV
Pathophysiology of septic shock
Abstract 6HSVLVDQGVHSWLFVKRFNUHVXOWIURPDQLQDGHTXDWHKRVWUHVSRQVHWRDQLQIHFWLRQ
ZKLFKFDXVHVRUJDQGVIXQFWLRQ7KHSURJUHVVLRQRIWKLVFRQGLWLRQLVPDQLIHVWHGEWKHRFFX-
UUHQFHRIVXFFHVVLYHFOLQLFDOVWDJHVUHVXOWLQJIURPWKHVVWHPLFLQÁDPPDWRUUHVSRQVHVHFRQ-
GDUWRWKHDFWLYDWLRQRIGLIIHUHQWLQÁDPPDWRUPHGLDWRUVOHDGLQJWRRUJDQGVIXQFWLRQ7KHUH
LVDKLJKEXUGHQRIHYLGHQFHRQWKHUROHRIHQGRWR[LQLQWKHSDWKRJHQHVLVRIVHSVLVDQGLWVFUXFLDO
UROHLQWULJJHULQJWKHLQÁDPPDWRUUHVSRQVHLQVHSVLVFDXVHGEJUDPQHJDWLYHEDFWHULD7KH
FRDJXODWLRQFDVFDGHDFWLYDWLRQLQVHSVLVSDWLHQWVLVSDUWRIWKHKRVW·VDGDSWLYHLPPXQHUHVSRQVH
WRLQIHFWLRQ7KHHQGRWKHOLXPLVWKHPDLQWDUJHWLQVHSVLVZKLFKLVPHWDEROLFDOODFWLYHDQGFDQ
$XWRUSDUDFRUUHVSRQGHQFLD
Correo electrónico:UIHUUHU#YKHEURQQHW 5)HUUHU
5(68,7$,Ð1'(/3$,(17(216(36,6SHOCK6e37,2
Fisiopatología del shock séptico
Luis Chiscano-Camóna,b,c
, Erika Plata-Menchacaa,b
, Juan Carlos Ruiz-Rodrígueza,b,c
y Ricard Ferrera,b,c,
*
a
Servicio de Medicina Intensiva, Hospital Universitario Vall d’Hebron, Barcelona, España
b
Grupo de Investigación Sepsis Organ Dysfunction and Resuscitation (SODIR), Vall d’Hebron Institut de Recerca (VHIR),
Hospital Universitari Vall d’Hebron, Barcelona, España
c
Departament de Medicina. Universitat Autònoma de Barcelona. Barcelona. España
KEYWORDS
Sepsis;
6HSWLFVKRFN
,QÁDPPDWRU
UHVSRQVH
WRNLQH
(QGRWKHOLXP
Endotoxin;
0LFURFLUFXODWLRQ
- 2. /KLVFDQR(3ODWD0HQFKDFD-5XL]5RGUtJXH]HWDO
UHVSRQGWRYDULRXVSKVLRORJLFDODQGSDWKRORJLFDOVWLPXOL$GDSWLQJWUHDWPHQWVWRVSHFLÀFSD-
WLHQWVZLOOEHDPDQGDWRUDQGSHUVRQDOL]HGVWUDWHJWRIRFXVRQ´KHPRGQDPLFFRKHUHQFHµ
)XWXUHUHVHDUFKVKRXOGDQVZHUZKHWKHUVWUDWHJLHVWRUHFUXLWPLFURFLUFXODWLRQFDQLPSURYHFOLQL-
FDORXWFRPHV
‹(OVHYLHU(VSDxD6/86(0,8$OOULJKWVUHVHUYHG
Introducción
La sepsis y el shockVpSWLFRVRQHOUHVXOWDGRGHODUHVSXHVWD
LQDGHFXDGDGHOKXpVSHGDXQDLQIHFFLyQTXHRFDVLRQDGLV-
IXQFLyQGHXQRRPiVyUJDQRV1
/DUHVSXHVWDLQÁDPDWRULDHQ
ODPDRUtDGHORVLQGLYLGXRVHVDGDSWDWLYDFRQWULEXHD
FRQWURODUODLQIHFFLyQ6LQHPEDUJRHQODVHSVLVVHSURGXFH
XQGHVHTXLOLEULRHQWUHORVPHFDQLVPRVSURLQÁDPDWRULRV
DQWLLQÁDPDWRULRV/DSURJUHVLyQGHHVWDFRQGLFLyQVHFDUDF-
WHUL]DSRUODDSDULFLyQVXFHVLYDGHHVWDGLRVFOtQLFRVTXHVRQ
HOUHVXOWDGRGHODUHVSXHVWDLQÁDPDWRULDVLVWpPLFDVHFXQGD-
ULDDODDFWLYDFLyQGHGLIHUHQWHVPHGLDGRUHVLQÁDPDWRULRV
TXHFRQGXFHQDGLVIXQFLyQRUJiQLFD2
(ÀJXUD (VWRLQFOXH
GLIHUHQWHVSURFHVRVÀVLROyJLFRVFRPRODDFWLYDFLyQGHGLIH-
UHQWHVOtQHDVFHOXODUHV PRQRFLWRVPDFUyIDJRVQHXWUyÀORV
FpOXODVHQGRWHOLDOHVSODTXHWDV ODSURGXFFLyQORFDOVLVWp-
PLFDGHFLWRFLQDVODHVWLPXODFLyQGHODFDVFDGDGHSURWHt-
QDVSODVPiWLFDV FRPRHOVLVWHPDGHOFRPSOHPHQWR OD
DFWLYDFLyQGHODVYtDVGHFRDJXODFLyQLQWUtQVHFD VLVWHPDGH
FRQWDFWR H[WUtQVHFDHOVLVWHPDÀEULQROtWLFRODSURGXF-
FLyQGHPHGLDGRUHVOLStGLFRVODDFWLYDFLyQGHODYtDGHO
y[LGRQtWULFR 12 ODSURGXFFLyQGHUDGLFDOHVOLEUHVODHVWL-
PXODFLyQGHORVOLQIRFLWRV%7VXVSURGXFWRVIHQyPHQRV
GHSURWHROLVLV3
HQWUHRWURV4
Figura 1 (YROXFLyQGHODVHSVLVRQODLQWHUDFFLyQGH3$03'$03FRQODFpOXODSUHVHQWDGRUDGHDQWtJHQRVVHLQLFLDODFDVFDGD
LQÁDPDWRULDGHODLQPXQLGDGLQQDWDDGDSWDWLYD/DLQÁDPDFLyQFDXVDGDxRWLVXODUVHFXQGDULDPHQWHGLVIXQFLyQRUJiQLFD(Q
DOJXQRVSDFLHQWHVVHJHQHUDXQHVWDGRGHLQPXQRSDUiOLVLVFDUDFWHUL]DGRSRUODDSDULFLyQGHLQIHFFLRQHVQRVRFRPLDOHVRSRUWXQLVWDV
UHDFWLYDFLRQHVYLUDOHVGHELGRDODDSRSWRVLVGHOWHMLGRLQPXQLWDULRODLQFDSDFLGDGUHODWLYDGHODVFpOXODV7 '$03 damage-
associated molecular patterns; 3$03pathogen-derived molecular patterns; 7/5 toll-like receptor.
- 3. Medicina Intensiva 46S1 (2022):1-13 3
Alteraciones celulares y moleculares
en la sepsis y el shock séptico
/DUHVSXHVWDLQÁDPDWRULDIUHQWHDXQDLQIHFFLyQVHLQLFLD
PHGLDQWHHOUHFRQRFLPLHQWRGHPROpFXODVGHULYDGDVGHOSD-
WyJHQR pathogen-derived molecular patterns3$036@ y
GHULYDGDV GHOKXpVSHG damage-associated molecular pat-
terns '$03@ .(OUHFRQRFLPLHQWRGHHVWDVPROpFXODVSRU
UHFHSWRUHVHVSHFtÀFRV toll-like receptors7/5@ HQODVX-
SHUÀFLHGHODVFpOXODVSUHVHQWDGRUDVGHDQWtJHQRV 3$ LQL-
FLDODFDVFDGDGHWUDQVFULSFLyQGHVXVWDQFLDVTXHSURGXFHQ
LQÁDPDFLyQDXPHQWRGHOPHWDEROLVPRFHOXODUDFWLYDFLyQ
GHODLQPXQLGDGDGDSWDWLYD5
)XQFLRQDQFRPR3$ODVFpOX-
ODVGHOVLVWHPDPRQRFLWRPDFUyIDJRODVFpOXODVGHQGUtWLFDV
ORVOLQIRFLWRV%FXDOTXLHUFpOXODGHORUJDQLVPRTXHH[SUHVH
HQVXPHPEUDQDGHWHUPLQDQWHVDQWLJpQLFRVUHODFLRQDGRV
FRQSURWHtQDVGHOFRPSOHMRPDRUGHKLVWRFRPSDWLELOLGDG
XDQGRODLQÁDPDFLyQHVH[FHVLYDFDXVDGDxRWLVXODUVH-
FXQGDULDPHQWHGLVIXQFLyQRUJiQLFD$VLPLVPRHQDOJXQRV
SDFLHQWHVODLQÁDPDFLyQH[FHVLYDVHDFRPSDxDSRVWHULRU-
PHQWHGHXQHVWDGRGHLQPXQRSDUiOLVLVFDUDFWHUL]DGRSRUOD
DSDULFLyQGHLQIHFFLRQHVQRVRFRPLDOHVLQIHFFLRQHVRSRUWX-
QLVWDVUHDFWLYDFLRQHVYLUDOHVGHELGRDODDSRSWRVLVGHOWHML-
GRLQPXQLWDULRHLQFDSDFLGDGUHODWLYDGHODVFpOXODV7
/D
UHVSXHVWDLQPXQROyJLFDGLVPLQXLGDIUHQWHDGHWHUPLQDGDV
infecciones8
VHGHEHDIHQyPHQRVFRPRODPHWLODFLyQGHO
$'1HQORVPRQRFLWRV
8QRGHORVLQGXFWRUHVGHODVHSVLVPHMRUFRQRFLGRVHVOD
HQGRWR[LQDROLSRSROLVDFiULGR /36 GHODVEDFWHULDV*UDP
QHJDWLYDV9
+DP~OWLSOHVSUXHEDVGHODLPSOLFDFLyQGHOD
HQGRWR[LQDHQODSDWRJpQHVLVGHODVHSVLV/DDGPLQLVWUDFLyQ
GH/36DDQLPDOHVGHH[SHULPHQWDFLyQHLQGLYLGXRVVDQRV
UHSURGXFHODPDRUSDUWHGHODVDOWHUDFLRQHVKHPRGLQiPL-
FDVGHULYDGDVGHOshockVpSWLFRODGLVIXQFLyQPXOWLRUJiQL-
FD(QHOVLVWHPDFDUGLRYDVFXODULQFUHPHQWDODIUHFXHQFLD
FDUGLDFDHOtQGLFHFDUGLDFRGLVPLQXHODVUHVLVWHQFLDV
YDVFXODUHVVLVWpPLFDVORTXHSURGXFHKLSRWHQVLyQ(QODPL-
FURYDVFXODWXUDDFWLYDODFRDJXODFLyQODKHPRVWDVLDSULPD-
ULDHOFRPSOHPHQWRHOVLVWHPDÀEULQROtWLFR(O/36DFW~D
HQHOHQGRWHOLRYDVFXODULQKLELHQGRODDFFLyQGHDQWLFRDJX-
ODQWHVHQGyJHQRVLQGXFLHQGRODVtQWHVLVGHUDGLFDOHVOLEUHV
HLQFUHPHQWDQGRODVtQWHVLVGH12
$GHPiVODHQGRWR[LQDDFWLYDORVPDFUyIDJRVLQGXFLHQGROD
VtQWHVLVGHFLWRFLQDVORVQHXWUyÀORVFDXVDQGROHVLyQHQGRWH-
OLDOPHGLDQWHODSURGXFFLyQGHDQLRQHVVXSHUy[LGRHQ]LPDV
SURWHROtWLFDV10
(OVLVWHPDGHOPRQRFLWRPDFUyIDJRHVODSULQ-
FLSDOGLDQDGHODDFFLyQGHO/36(OVXHURKXPDQRODVPHP-
EUDQDVFHOXODUHVFRQWLHQHQSURWHtQDVUHFHSWRUHVTXHVH
XQHQGHIRUPDHVSHFtÀFDDO/36SDUDUHJXODUODFRPSOHMDUHV-
SXHVWDLQPXQROyJLFDGHOKXpVSHGDHVWDWR[LQDEDFWHULDQD
$GHPiVVHKDQFDUDFWHUL]DGRIDFWRUHVVROXEOHVTXHVHXQHQD
ODHQGRWR[LQDPRGXODQVXVHIHFWRVELROyJLFRVFRPRODSUR-
WHtQDGHXQLyQDO/36 LPS-binding protein /%3@ ODSURWHtQD
EDFWHULFLGDLQFUHPHQWDGRUDGHODSHUPHDELOLGDG bacterici-
dal permeability increasing protein %3,@ (O'UHFHSWRU
GHO/36WLHQHHOSDSHOGHWUDQVIHULUODVHxDOGHO/36YtD7/5
7DPELpQWLHQHLQWHUpVDSOLFDELOLGDGODSUHVHSVLQDRVHJ-
PHQWR1WHUPLQDOGHO'TXHVHXWLOL]DFRPRELRPDUFDGRU
de la sepsis
$VLPLVPRGXUDQWHODKHPRDGVRUFLyQGHHQ-
dotoxina en los pacientes con sepsis13
VHKDQGHVFULWRH[WHQ-
VRVFDPELRVHQODPRGXODFLyQGHODUHVSXHVWDLQÁDPDWRULD
/DXQLyQGH3$03'$03DODV3$LQGXFHXQDDFWLYDFLyQ
FHOXODUTXHOOHYDDODWUDQVORFDFLyQQXFOHDUGHOIDFWRU1)N%
HQODVFpOXODV%DFWLYDGDVHQFRQVHFXHQFLDODH[SUHVLyQ
GHFLWRFLQDVSURLQÁDPDWRULDV LQWHUOHXFLQD,/@,/,/
IDFWRUGHQHFURVLVWXPRUDODOID71)Ş@HLQWHUIHUyQ
,)1@ 'HIRUPDVHFXQGDULDVHSURGXFHODDFWLYDFLyQGH
RWUDVFLWRFLQDV ,)1,/,/ GHOVLVWHPDGHFRPSOHPHQ-
WRGHODFDVFDGDGHFRDJXODFLyQDVtFRPRODUHJXODFLyQD
ODEDMDGHORVFRPSRQHQWHVGHOVLVWHPDLQPXQLWDULRDGDSWD-
tivo14
(QODWDEODVHPHQFLRQDQORVHIHFWRVGHORVSULQFL-
SDOHVPHGLDGRUHVLQÁDPDWRULRVHQODVHSVLV
/RVQHXWUyÀORVDGHPiVVHOLEHUDQHQVXVIRUPDVLQPDGX-
UDVGHVGHODPHGXODyVHD$ODFWLYDUVHSRUORVPHGLDGRUHV
SUHVHQWDQFDSDFLGDGIDJRFtWLFDUHGXFLGD
/RVQHXWUyÀORV
DFWLYDGRVIRUPDUiQUHGHVH[WUDFHOXODUHVHQHOWHMLGRLQÁD-
Tabla 1 3ULQFLSDOHVPHGLDGRUHVLQÁDPDWRULRVHQODVHSVLV
(OHPHQWR DUiFWHU /XJDUGHVtQWHVLV $FFLRQHVPiVLPSRUWDQWHV
IL-1 3URLQÁDPDWRULD pOXODVPRQRQXFOHDUHV 3LUyJHQRLQGXFWRUGHVtQWHVLVGH,/,/71))DFWRU
TXLPLRWiFWLFRGHQHXWUyÀORVPRQRFLWRVOLQIRFLWRV
,QGXFWRUGHPHGLDGRUHVOLStGLFRVHVWLPXODVtQWHVLVGH12
IL-2 $QWLLQÁDPDWRULD /LQIRFLWRV7
FRODERUDGRUHV
)DFWRUGHFUHFLPLHQWRGHFpOXODV7LQGXFHODSUROLIHUDFLyQ
GHWRGRVORVWLSRVGHVXESREODFLRQHVGHOLQIRFLWRV7FpOXODV
WLSR%DFWLYDV(VWLPXODODVtQWHVLVGHLQWHUIHUyQJDPPD
HLQGXFHOLEHUDFLyQGH,/71)Şş
IL-4 $QWLLQÁDPDWRULD /LQIRFLWRV7
FRODERUDGRUHV
PDVWRFLWRVEDVyÀORV
$FW~DHQHOPDFUyIDJREORTXHDQGRODVtQWHVLVGHFLWRFLQDV
WLHQHDFWLYLGDGFLWRWy[LFDHLQKLEHODSURGXFFLyQGH12
IL-6 3URLQÁDPDWRULD
y
DQWLLQÁDPDWRULD
0RQRFLWRVPDFUyIDJRV
células endoteliales
ÀEUREODVWRV
3LUyJHQRLQGXFWRUGHVtQWHVLVGHLQPXQRJOREXOLQDV
GLIHUHQFLDFLyQGHOLQIRFLWRV%DFWLYDFLyQGHOLQIRFLWRV7
PRGXODFLyQGHKHPDWRSRHVLV6HHQFDUJDGHODVtQWHVLV
GHSURWHtQDVGHIDVHDJXGDHQHOKtJDGR
IL-8 3URLQÁDPDWRULD 0RQRFLWRVPDFUyIDJRV
células endoteliales
ÀEUREODVWRV
)DFWRUTXLPLRWiFWLFRDFWLYDGRUGHQHXWUyÀORV5HJXODOD
SURGXFFLyQGHSURWHtQDVGHDGKHVLyQODIRUPDFLyQGH
OtSLGRVELRDFWLYRVTXHLQGXFHQODDPSOLÀFDFLyQGHODOHVLyQ
LQÁDPDWRULDORFDOOHVLyQWLVXODU
- 4. /KLVFDQR(3ODWD0HQFKDFD-5XL]5RGUtJXH]HWDO
Tabla 1 3ULQFLSDOHVPHGLDGRUHVLQÁDPDWRULRVHQODVHSVLV(cont.)
IL-10 $QWLLQÁDPDWRULD /LQIRFLWRV7OLQIRFLWRV%
PRQRFLWRVPDFUyIDJRV
,QKLEHODVtQWHVLVGHFLWRFLQDVUDGLFDOHVOLEUHV12OD
H[SUHVLyQGH0+FODVH,,ODSUROLIHUDFLyQGHOLQIRFLWRV7
FRODERUDGRUHVODDFWLYLGDGSURFRDJXODQWHGHOIDFWRUWLVXODU
(VWLPXODORVOLQIRFLWRV%HOGHVDUUROORGHFpOXODV7
FLWRWy[LFDVODSURGXFFLyQGHOLQIRFLWRVPDVWRFLWRV
IL-11 $QWLLQÁDPDWRULD pOXODVGHOHVWURPD
GHPpGXODyVHD
)DFWRUGHFUHFLPLHQWRKHPDWRSRpWLFR,QPXQRPRGXODFLyQ
LQKLELHQGRHO1)ŧ%ODVtQWHVLVGH,/,/LQWHUIHUyQ
71)
IL-12 3URLQÁDPDWRULD 0RQRFLWRVPDFUyIDJRV
OLQIRFLWRV%
$FWLYDFLyQGHOLQIRFLWRV7+HVWLPXODODSURGXFFLyQ
FLWRWR[LFLGDGGHORVOLQIRFLWRV7FLWRWy[LFRVFpOXODV
natural killer(VWLPXODODSURGXFFLyQGHLQWHUIHUyQJDPPD
IL-13 $QWLLQÁDPDWRULD /LQIRFLWRV7+7+
OLQIRFLWRV7
FLWRWy[LFRV'
5HJXODFLyQGHODIXQFLyQGHPRQRFLWRVOLQIRFLWRV%0RGXOD
ODSURGXFFLyQGH,/,/71)SURWHtQDLQÁDPDWRULDGHO
PDFUyIDJRWLSR,QWHUYLHQHHQODH[SUHVLyQGHPROpFXODV
GHVXSHUÀFLHHQPRQRFLWRVPDFUyIDJRV LQWHJULQDV$J0+
FODVH,,UHFHSWRU') HLQKLEH1)ŧ%
IL-15 3URLQÁDPDWRULD pOXODVPRQRQXFOHDUHV
FpOXODVHSLWHOLDOHV
ÀEUREODVWRVFpOXODV
endoteliales
(VWLPXODODSUROLIHUDFLyQGHOLQIRFLWRV7FpOXODV
PRQRQXFOHDUHVLQGXFHODJHQHUDFLyQGHFpOXODVFLWROtWLFDV
HLQKLEHODDSRSWRVLV
IL-18 3URLQÁDPDWRULD 0DFUyIDJRVPRQRFLWRV
OLQIRFLWRV7%FpOXODV
GH.XSIIHU
(VWLPXODODSURGXFFLyQGHLQWHUIHUyQJDPPDDFWLYD
OLQIRFLWRV7+HVWLPXODQGRODSURGXFFLyQODFLWRWR[LFLGDG
GHFpOXODV7FLWRWy[LFDVFpOXODVnatural killer
71)Ş 3URLQÁDPDWRULD 0DFUyIDJRVPRQRFLWRV
OLQIRFLWRV%FpOXODV17
FpOXODVHQGRWHOLDOHV
PLRFLWRVDVWURFLWRV
3URGXFHÀHEUHDQRUH[LDSpUGLGDGHSHVR$SRSWRVLV
FLWRWR[LFLGDGFHOXODULQHVSHFtÀFDHVWLPXODODUHVSXHVWD
SUROLIHUDWLYDGHORVOLQIRFLWRV7PRGXODODVUHVSXHVWDV
GHORVOLQIRFLWRV7%DXPHQWDODVtQWHVLVGHPROpFXODV
GHDGKHVLyQIDFLOLWDQGRODDGKHUHQFLDGHORVOLQIRFLWRVDODV
FpOXODVHQGRWHOLDOHVDXPHQWDODIDJRFLWRVLVODDGKHUHQFLD
GHORVQHXWUyÀORVDODVFpOXODVHQGRWHOLDOHVVXPLJUDFLyQ
IXHUDGHORVYDVRVDXPHQWDODDJUHJDFLyQSODTXHWDULD
ODFRDJXODFLyQSRUPHGLRGHODXPHQWRGHODVtQWHVLV
OLEHUDFLyQGHOIDFWRUWLVXODUDXPHQWDODÀEULQROLVLVPHGLDQWH
HODXPHQWRGHODVtQWHVLVGHW3$HVWLPXODODVtQWHVLVGH,/
,/H,/$7+SURVWDJODQGLQDV$XPHQWDOD
JOXFRJHQROLVLV(VWLPXODODDQJLRJpQHVLVODOLEHUDFLyQ
GHFRODJHQDVDVODPXOWLSOLFDFLyQGHÀEUREODVWRV
71)ş 3URLQÁDPDWRULD /LQIRFLWRV7FLWRWy[LFRV
DFWLYDGRV'OLQIRFLWRV
7K'OLQIRFLWRV%
DVWURFLWRV
DXVDFLWROLVLVDSRSWRVLVQHFURVLVGHFpOXODVWXPRUDOHV
,QGXFHODH[SUHVLyQGH$JGHKLVWRFRPSDWLELOLGDGFODVH,
VREUHODPHPEUDQDGHFpOXODVHSLWHOLDOHVGHPROpFXODV
GHDGKHVLyQVREUHODPHPEUDQDGHOLQIRFLWRVIDFWRU
HVWLPXODGRUGHOFUHFLPLHQWRGHOLQIRFLWRV%DFWLYDGRV
DFWLYDFLyQGH301GHRVWHRFODVWRVDFWLYLGDGDQWLYLUDO
$GUHQRPHGXOLQD +RUPRQD
péptida
de efecto
YDVRGLODWDGRU
RGLÀFDGDSRUHOJHQ
ADM.(O$'0
es un péptidoTXH
VHHQFXHQWUDHQWRGRV
ORVWHMLGRVHQOD
FLUFXODFLyQVLVWpPLFD
,GHQWLÀFDGDLQLFLDOPHQWHFRPRXQYDVRGLODWDGRURWURV
HIHFWRVGHO$'0VRQODHVWLPXODFLyQGHOFUHFLPLHQWRGH
nuevos YDVRVVDQJXtQHRV (DQJLRJpQHVLV HODXPHQWRGH
ODWROHUDQFLDGHODVFpOXODVDOHVWUpVR[LGDWLYRHOGDxR
KLSy[LFR
%UDGLFLQLQD 9DVRGLODWDGRU La actividad del VLVWHPD
FDOLFUHtQDFLQLQDSURGXFH
EUDGLFLQLQDSRU
GHVGREODPLHQWR
SURWHROtWLFR de su
SUHFXUVRUFLQLQyJHQR
FLQLQyJHQRGHHOHYDGR
SHVRPROHFXODU (30
PHGLDQWHODHQ]LPD de la
FLQLQRJHQDVD
/DEUDGLFLQLQDFDXVDYDVRGLODWDFLyQSRUPHGLRGHOD
VHFUHFLyQGHSURVWDFLFOLQDVy[LGRQtWULFRHOIDFWRU
KLSHUSRODUL]DQWHGHULYDGRGHOHQGRWHOLR/DEUDGLFLQLQD
es un potente YDVRGLODWDGRU dependiente del endotelioTXH
SURYRFDODFRQWUDFFLyQGHOP~VFXOROLVRQRYDVFXODUDXPHQWD
la SHUPHDELOLGDGYDVFXODUWDPELpQHVWiUHODFLRQDGRFRQ
HOPHFDQLVPRGHOGRORU(QFLHUWRVDVSHFWRVDFW~DGHPDQHUD
VLPLODUDODKLVWDPLQDDOLJXDOTXHHVWDVHVHFUHWD
en las vénulas y no en las DUWHULRODV
- 5. Medicina Intensiva 46S1 (2022):1-13 5
Tabla 1 3ULQFLSDOHVPHGLDGRUHVLQÁDPDWRULRVHQODVHSVLV(cont.)
Ð[LGRQtWULFR 9DVRGLODWDGRU
FRDJXORSDWtD
(QGRWHOLRYDVFXODU6H
VLQWHWL]DDSDUWLUGHO
QLWUyJHQRGHODJXDQLGLQD
WHUPLQDOGHODPLQRiFLGR
/DUJLQLQDSRUODDFFLyQ
GHXQD12VLQWHWDVD
12V SURGXFLHQGR12
/FLWUXOLQD
(O12DOLQKLELUODDGKHVLyQSODTXHWDULDDOHQGRWHOLR
YDVFXODUGDxDGRFRQWULEXHDHYLWDUHOSDVRLQLFLDOTXHOOHYD
DODDFWLYDFLyQFRQHOORODDJUHJDFLyQROLEHUDFLyQ
SODTXHWDULD8QDSURGXFFLyQH[FHVLYDGH12FDXVDOD
UHODMDFLyQGHODVDUWHULDVXQDSUHVLyQVDQJXtQHD
H[FHVLYDPHQWHEDMD
3URVWDJODQGLQDV 'LYHUVR
HQIXQFLyQ
de tipos de
SURVWDJODQGLQDV
SURVWDFLFOLQD,2
3*,2
SURVWDJODQGLQD
E2 3*(2) y
SURVWDJODQGLQD
)Ş 3*)Ş)
6HVLQWHWL]DQDSDUWLU
GHORViFLGRVJUDVRV
HVHQFLDOHVSRUODDFFLyQ
GHGLIHUHQWHVHQ]LPDV
FRPRFLFORR[LJHQDVDV
OLSRR[LJHQDVDVHO
FLWRFURPR3
SHUR[LGDVDVHWF
/DVSURVWDJODQGLQDVWLHQHQHIHFWRHQODUHVLVWHQFLDYDVFXODU
FRUWLFDOUHQDOSURGXFHXQDXPHQWRGHOÁXMRVDQJXtQHR
FRUWLFDOUHQDOHOFRQVLJXLHQWHDXPHQWRGHOYROXPHQ
LQWUDFHOXODUGLVPLQXFLyQGHODUHVLVWHQFLDSHULIpULFD
'HHVWDPDQHUDMXQWRFRQODKRUPRQD $'+ y la DOGRVWHURQD
UHJXODQYtDKRUPRQDOODSUHVLyQDUWHULDO,QWHUYLHQHQ
HQODUHVSXHVWDLQÁDPDWRULDYDVRGLODWDFLyQDXPHQWR
GHODSHUPHDELOLGDGGHORVWHMLGRVTXHIDFLOLWDHOSDVR
de los leucocitosDQWLDJUHJDQWHSODTXHWDULRHVWtPXORGH
ODVWHUPLQDFLRQHVQHUYLRVDVGHOGRORUHWF
Endotoxina o
OLSRSROLVDFiULGR
/36
3URLQÁDPDWRULR 'LYHUVRVFRPSRQHQWHVGH
ODSDUHGGHODVEDFWHULDV
*UDPSRVLWLYDV
SHSWLGRJOXFDQRV
PXUDPLOGLSpSWLFRV
iFLGROLSRWHLFRLFR
H[RWR[LQDV H[RWR[LQD$
de Pseudomonas
aeruginosa7667
GHOVtQGURPHGHshock
Wy[LFRHVWDÀORFyFLFR
WR[LQDHULWURJpQLFDGHO
HVWUHSWRFRFRJUXSR$
DQWtJHQRVULFNHWWVLDOHV
YtULFRVI~QJLFRV
OLSRDUDELQRPDQDQR
SXHGHQGHVHQFDGHQDU
ODUHVSXHVWDLQÁDPDWRULD
(OLQGXFWRUGHODUHVSXHVWDLQÁDPDWRULDPHMRUFRQRFLGR
HVODHQGRWR[LQDROLSRSROLVDFiULGR /36 GHODVEDFWHULDV
*UDPQHJDWLYDV/DDGPLQLVWUDFLyQGH/36HQ
H[SHULPHQWDFLyQDQLPDOHLQGLYLGXRVVDQRVUHSURGXFHOD
PDRUSDUWHGHODVDOWHUDFLRQHVKHPRGLQiPLFDVGHOshock
VpSWLFRODGLVIXQFLyQPXOWLRUJiQLFD(QHOVLVWHPD
FDUGLRYDVFXODULQFUHPHQWDODIUHFXHQFLDFDUGLDFDHOtQGLFH
FDUGLDFRGLVPLQXHODVUHVLVWHQFLDVYDVFXODUHVVLVWpPLFDV
KDVWDODKLSRWHQVLyQ$QLYHOPLFURYDVFXODUODHQGRWR[LQD
DFWLYDODFRDJXODFLyQORVVLVWHPDVGHFRQWDFWR
GHOFRPSOHPHQWRÀEULQROtWLFR$FW~DHQHOHQGRWHOLR
LQKLELHQGRODDFFLyQGHDQWLFRDJXODQWHVHQGyJHQRV
SURGXFLHQGRUDGLFDOHVOLEUHVHLQFUHPHQWDQGRODSURGXFFLyQ
GH12$GHPiVDFWLYDORVPDFUyIDJRVLQGXFLHQGRODVtQWHVLV
GHFLWRFLQDVORVQHXWUyÀORVFDXVDQGROHVLyQHQGRWHOLDO
PHGLDQWHODSURGXFFLyQGHDQLRQHVVXSHUy[LGRHQ]LPDV
SURWHROtWLFDV
PDGR
TXHLQPRYLOL]DQDOSDWyJHQRHVWLPXODQRWUDVVXV-
WDQFLDVLQÁDPDWRULDV(VWRVSURFHVRVFRQOOHYDQODDFWLYDFLyQ
GHODFDVFDGDGHODFRDJXODFLyQ18
(ÀJXUD 'HKHFKRORV
SDFLHQWHVVpSWLFRVFRQXQDHYROXFLyQFOtQLFDGHVIDYRUDEOH
SUHVHQWDQXQDXPHQWRGHODVUHGHVGHQHXWUyÀORWLVXODU19
(OVLVWHPDGHOFRPSOHPHQWRWDPELpQHVWiLPSOLFDGRHQOD
ÀVLRSDWRORJtDGHODVHSVLV7DQWRODIUDFFLyQD D FRPR
VXUHFHSWRU D5 VRQDFWRUHVUHOHYDQWHV7UDVODXQLyQFRQ
ORVQHXWUyÀORVHVWHHOHPHQWRGHOVLVWHPDGHFRPSOHPHQWR
SHQHWUDHQODFpOXODGRQGH3$03'$03LQGXFHQODUHG
QHXWURItOLFDTXHJHQHUDGDxRR[LGDWLYRFRDJXORSDWtDFD-
UDFWHUL]DGDSRUXQHVWDGRSURWURPEyWLFREORTXHRÀEULQROt-
tico20
8QDDFWLYDFLyQH[FHVLYDGHDFDXVDDSRSWRVLVGHORV
OLQIRFLWRVGLVIXQFLyQGHORVQHXWUyÀORV21
([LVWHXQDKHWHURJHQHLGDGRYDULDELOLGDGLQWHULQGLYLGXDO
FRQVLGHUDEOHHQODUHVSXHVWDLQÁDPDWRULDGHVFULWDTXHVH
PRGXODSRUYDULRVIDFWRUHVFRPRODKLSRJDPPDJOREXOLQH-
PLD22
ORTXHPRWLYDGLÀFXOWDGHVHQHOGLDJQyVWLFRHOWUDWD-
PLHQWR23
%HUPHMR0DUWLQHWDOKDQGHVFULWRKDVWD
LQPXQRIHQRWLSRVGLVWLQWRVDVRFLDGRVFRQODLQPXQRVXSUH-
VLyQHOGHVHTXLOLEULRLQPXQROyJLFRHQODVHSVLV/RVIHQRWL-
SRVTXHGHVFULEHQVRQODVDOWHUDFLRQHVFXDQWLWDWLYDV
FXDOLWDWLYDVHQODV3$ORVOLQIRFLWRV%7ODVFpOXODV1. y
ORVQHXWUyÀORV7DPELpQGHVFULEHQDOWHUDFLRQHVHQODSUR-
SRUFLyQGHODVFpOXODV7UHJXODGRUDVHOLQFUHPHQWRHQOD
H[SUHVLyQGHODSURWHtQDprogrammed cell death protein-1
3' KLSRJDPPDJOREXOLQHPLDKLSHUFLWRFLQHPLDGLVIXQ-
FLyQGHOVLVWHPDGHFRPSOHPHQWRHOLPSRUWDQWHSDSHOGH
ODVUHGHVH[WUDFHOXODUHVGHQHXWUyÀORHQHOGHVDUUROORGHOD
LQIHFFLyQ24
/RVDXWRUHVSURSRQHQTXHVXHVWXGLRFRQGX]FDD
XQWUDWDPLHQWRSHUVRQDOL]DGR(VWH~OWLPRDVSHFWRQRVH
WUDWDHQHVWDUHYLVLyQ
Endotelio y coagulopatía en la sepsis
/DDFWLYDFLyQGHODFDVFDGDGHODFRDJXODFLyQHQHOSDFLHQWH
VpSWLFRVHUHFRQRFHFRPRSDUWHGHXQDUHVSXHVWDLQPXQLWD-
ULDDGDSWDWLYDGHOKXpVSHGDODLQIHFFLyQ25
6LQHPEDUJROD
FRDJXODFLyQLQWUDYDVFXODUGLVHPLQDGD ,' TXHSXHGHDSD-
UHFHUHQSDFLHQWHVFRQVHSVLVHVHOUHVXOWDGRGHXQDDFWLYD-
FLyQGHVPHGLGDGHOHWpUHDGHODFRDJXODFLyQ26
6HWUDWDXQ
VtQGURPHDGTXLULGRFDUDFWHUL]DGRSRUDFWLYDFLyQGHORVIDF-
WRUHVGHODFRDJXODFLyQRULJLQDGRVDUDt]GHXQGDxRHQHO
- 6. /KLVFDQR(3ODWD0HQFKDFD-5XL]5RGUtJXH]HWDO
OHFKRPLFURYDVFXODUTXHSXHGHOOHJDUDFDXVDUGLVIXQFLyQ
RUJiQLFDGHSHQGLHQGRGHVXPDJQLWXG
$OFDQ]DXQDJUDQ
YDULHGDGGHHQWLGDGHVFOtQLFDVFRQIHQyPHQRVKHPRUUiJL-
cos en etapas iniciales28
DOWHUDFLRQHVHQODVSUXHEDVGHFRD-
JXODFLyQRLVTXHPLDGLVWDOGHODVH[WUHPLGDGHVSRU
IHQyPHQRVWURPEyWLFRV29
6RQORVIDFWRUHVFODYHTXHFRQ-
WULEXHQHQOD,'ODDFWLYDFLyQGHODFDVFDGDGHODFRDJX-
ODFLyQODDJUHJDFLyQSODTXHWDULDHOGDxRHQGRWHOLDO
Activación de la cascada de coagulación
EORTXHRÀEULQROtWLFR
/DVHSVLVVHFDUDFWHUL]DSRUXQHVWDGRSURWURPEyWLFRMXQWR
FRQEORTXHRÀEULQROtWLFRDPERVVRQORVPHFDQLVPRVIXQ-
GDPHQWDOHVGHOD,'+DXQDVHULHGHPHGLDGRUHVLQÁDPD-
WRULRVTXHSURPXHYHQODDFWLYDFLyQGHODWURPELQDHQODYtD
FRP~QGHODFRDJXODFLyQFRPRSDUWHGHODUHVSXHVWDGHO
KXpVSHGDODLQIHFFLyQ30
(OIDFWRUWLVXODU )7 SRUVXSDUWH
FRPRDFWLYDGRUGHODYtDH[WUtQVHFDVHH[SUHVDHQPDFUyID-
JRVPRQRFLWRVFpOXODVHQGRWHOLDOHV31
/DDFFLyQFRQMXJDGD
GH3$03'$03HVHOIDFWRUGHWHUPLQDQWHSDUDHOLQLFLRGHO
SURFHVR$GHPiVLQWHUYLHQHQRWURVPHGLDGRUHVKXPRUDOHV
FRPR,/,/71)ŞHODVWDVDFDWHSVLQD*HOVLVWHPDGHO
FRPSOHPHQWRTXHWDPELpQVRQIDFLOLWDGRUHVGHOSURFHVR32
,QFOXVRODVUHGHVH[WUDFHOXODUHVGHQHXWUyILORVDFWLYDGRV
WDPELpQHVWiQLPSOLFDGDV33
1RVHSURGXFHH[FOXVLYDPHQWHXQDDFWLYDFLyQGHODFDVFD-
GDGHODFRDJXODFLyQVLQRGHORVHOHPHQWRVTXHODUHJXODQ
FRPRHOVLVWHPDILEULQROtWLFRTXHVHDOWHUDQHQWUDQHQ
GLVIXQFLyQ6HKDOODQYDORUHVHOHYDGRVGHOLQKLELGRUWLVXODU
GHSODVPLQyJHQRTXHSURGXFHQXQYLUDMHDXQHVWDGRGH
WURPERÀOLDHQOD,'34
'HKHFKRVXFRQFHQWUDFLyQSODVPi-
WLFDVHKDUHODFLRQDGRFRQGLVIXQFLyQRUJiQLFDPRUWDOLGDG
en la sepsis35
7DPELpQKDXQDUHJXODFLyQDODEDMDGHORV
LQKLELGRUHVGHODWURPELQD36
HOSODVPLQyJHQR
HLQFUHPHQ-
WRGHOLQKLELGRUGHODFWLYDGRUGHOSODVPLQyJHQRORTXHFDX-
VDXQEORTXHRÀEULQROtWLFR7DPELpQVHREVHUYDUHGXFFLyQGH
ODVFRQFHQWUDFLRQHVSODVPiWLFDVGHSURWHtQDSRUORTXHVH
KDFRQYHUWLGRHQIDFWRUSURQyVWLFRGHPRUWDOLGDG38
/DLQKLELFLyQGHODVSURWHtQDVSURFRDJXODQWHVSRUHOHQGR-
WHOLRVHSURGXFHDWUDYpVGHORVVLVWHPDVDQWLFRDJXODQWHVÀ-
VLROyJLFRVODYtDGHODSURWHtQDHOVLVWHPDGHOD
DQWLWURPELQD,,,HOLQKLELGRUGHO)7(QODVHSVLVVHSURGXFH
XQDGLVPLQXFLyQGHHVWRVLQKLELGRUHVSRUFRQVXPRUHGXF-
FLyQGHVXVtQWHVLVRGHJUDGDFLyQPHGLDQWHHODVWDVDV/D
FRQVHFXHQFLDGHHOORHVODDSDULFLyQGHXQHVWDGRSURWURP-
EyWLFRFDUDFWHUL]DGRSRUXQDFRDJXODFLyQDFWLYDGDHLQVXÀ-
FLHQFLDGHORVVLVWHPDVLQKLELGRUHVGHODFRDJXODFLyQ
Disfunción endotelial
(OHQGRWHOLRHVHOyUJDQRGLDQDIXQGDPHQWDOGHODVHSVLV39
y
VHFDUDFWHUL]DSRUVHUPHWDEyOLFDPHQWHDFWLYRWHQHUOD
FDSDFLGDGSDUDUHVSRQGHUDGLYHUVRVHVWtPXORVÀVLROyJLFRV
SDWROyJLFRV(QWUHVXVIXQFLRQHVHVWiQHOPDQWHQLPLHQWRGH
ODKHPRVWDVLDODÁXLGH]GHODVDQJUH(OHQGRWHOLRGHVHP-
SHxDXQSDSHOFODYHHQODUHJXODFLyQGHODSUHVLyQDUWHULDO
HVIXQGDPHQWDOHQORVPHFDQLVPRVLQÁDPDWRULRV/DVFpOX-
ODVHQGRWHOLDOHVPDQWLHQHQXQGHOLFDGRHTXLOLEULRGHOWRQR
YDVFXODUODDGKHVLyQGHODVFpOXODVVDQJXtQHDVODFRDJXOD-
FLyQ3RUGLYHUVRVPHFDQLVPRVHOHQGRWHOLRHVFDSD]GH
FRQWURODUHOWRQRYDVRPRWRUPDQWHQHUODÁXLGH]GHODVDQ-
Figura 2 )LVLRSDWRORJtDGHODVHSVLV/DXQLyQGH3$03'$03DODV3$LQGXFHXQDDFWLYDFLyQGHHOHPHQWRVLQÁDPDWRULRVTXH
FRQOOHYDODSURGXFFLyQGHFLWRFLQDVODDFWLYDFLyQGHQHXWUyÀORVODDFWLYDFLyQGHOVLVWHPDGHOFRPSOHPHQWRGHODFDVFDGDGH
FRDJXODFLyQFDXVDUiGLVIXQFLyQRUJiQLFDHQFDVRGHXQDUHVSXHVWDGHVHTXLOLEUDGD,'FRDJXODFLyQLQWUDYDVFXODUGLVHPLQDGD
3$FpOXODSUHVHQWDGRUDGHDQWtJHQRV,/LQWHUOHXFLQD '$03V damage-associated molecular patterns; *6)*06)IDFWRU
HVWLPXODGRU GH FRORQLDV /3% LPS-binding protein; 3$03 pathogen-derived molecular patterns; 526 HVSHFLHV UHDFWLYDV GH
R[tJHQR 71)IDFWRUQHFURVLVWXPRUDO 7/5: toll-like receptors.
- 7. Medicina Intensiva 46S1 (2022):1-13
JUHHLQWHUYHQLUHQODUHVSXHVWDLQÁDPDWRULD(QFRQGLFLRQHV
ÀVLROyJLFDVVHFDUDFWHUL]DIXQGDPHQWDOPHQWHSRUVXVSUR-
SLHGDGHVDQWLWURPEyWLFDVDQWLFRDJXODQWHVSURÀEULQROtWLFDV
DQWLDJUHJDQWHVSODTXHWDULDVRPRFRQVHFXHQFLDGHOD
HVWLPXODFLyQGHYDULDVFLWRFLQDV 71)Ş,/RWURV
PHGLDGRUHVLQÁDPDWRULRVFRPRHOFRPSOHPHQWRDFWLYDGR
HVWDVSURSLHGDGHVHQGRWHOLDOHVVHYHQSURIXQGDPHQWH
DOWHUDGDVVHSURGXFHXQDWUDQVIRUPDFLyQHQGRWHOLDO
GHQRPLQDGD´DFWLYDFLyQGHOHQGRWHOLRµ(VWDVHFDUDFWHUL]D
SRUXQDVXSHUILFLHHQGRWHOLDOSURFRDJXODQWHXQEORTXHR
ÀEULQROtWLFRPHGLDGRSRUOLEHUDFLyQPDVLYDGHOLQKLELGRUGHO
DFWLYDGRUGHOSODVPLQyJHQRODH[SUHVLyQGHPROpFXODVGH
DGKHVLyQODSURGXFFLyQGHPHGLDGRUHVLQIODPDWRULRV
DJHQWHVYDVRDFWLYRV
Agregación plaquetaria
/DWURPERFLWRSHQLDHQODVHSVLVVHGHEHDGLYHUVRVIDFWRUHV
)XQGDPHQWDOPHQWHORVPHGLDGRUHVLQÁDPDWRULRVVXSULPHQ
ODSURGXFFLyQSODTXHWDULD2WURPHFDQLVPRHVHODXPHQWR
GHOFRQVXPRGHELGRDTXHODVSODTXHWDVSDUWLFLSDQHQOD
,'DOVHUDFWLYDGDVSRUODWURPELQDHOVLVWHPDGHFRPSOH-
PHQWRHOIDFWRUGHYRQ:LOOHEUDQG )Y: 42
Alteraciones hemodinámicas macrovasculares
y microvasculares en la sepsis y el shock
séptico
Alteraciones macrocirculatorias en la sepsis
$QLYHOPDFURKHPRGLQiPLFRVHKDFRQVLGHUDGRKLVWyULFD-
PHQWHTXHHOVKRFNVpSWLFRRFXUUHHQGLIHUHQWHVIDVHV(QOD
SULPHUDIDVHKDXQDKLSRYROHPLDFDXVDGDSULQFLSDOPHQWH
SRUSpUGLGDVUHODWLYDVGHYROXPHQGHELGDVDODXPHQWRGHOD
FDSDFLWDQFLDYHQRVDODGLVPLQXFLyQGHOYROXPHQHVWUHVDGR
TXHGHWHUPLQDHOUHWRUQRYHQRVR43
7DPELpQLQÁXHQHQOD
KLSRYROHPLDODVSpUGLGDVDEVROXWDVGHYROXPHQGHELGDVD
ÀHEUHGLVPLQXFLyQGHODLQJHVWDVDQJUDGRSpUGLGDVJDV-
WURLQWHVWLQDOHVHWF/DVHJXQGDIDVHHVODKLSHUGLQiPLFDGH
ODVHSVLVODWHUFHUDGLVIXQFLyQFDUGLDFDTXHFRQGXFHD
GLVIXQFLyQPXOWLRUJiQLFD44
DXQTXHODFDUGLRPLRSDWtDDVR-
FLDGDDVHSVLVVHSXHGHDGHODQWDUHVWDUSUHVHQWHGHVGHHO
inicio45
(VWDVIDVHVSXHGHQVHULQWHUFDPELDEOHVVLHPSUHFDUDFWH-
UL]DGDVSRUVHUXQSUREOHPDSULQFLSDOPHQWHGHFDUiFWHUGLV-
WULEXWLYR/DIDVHWHPSUDQDKLSHUGLQiPLFDVHFDUDFWHUL]D
SRUDOWRJDVWRFDUGLDFREDMDVUHVLVWHQFLDVSHULIpULFDVHKL-
SRYROHPLDUHODWLYD'HVSXpVKDXQDIDVHKLSRGLQiPLFDFRQ
EDMRJDVWRSREUHSHUIXVLyQGLVWDOGLVIXQFLyQPXOWLRUJi
nica46
OiVLFDPHQWHODHYDOXDFLyQPDFURKHPRGLQiPLFDVHKD
OOHYDGRDFDERPHGLDQWHFDWHWHUL]DFLyQGHODDUWHULDSXOPR-
QDU6LQHPEDUJRHOHPSOHRGHODHFRFDUGLRJUDItDKDPHMR-
UDGRVXVWDQFLDOPHQWHHVWDHYDOXDFLyQGLULJLpQGRODKDFLDXQ
PDRUGLQDPLVPR
$GHPiVGHODHYDOXDFLyQGHODIUDFFLyQ
GHHHFFLyQ )( HQODHFRFDUGLRJUDItDVHSRGUtDLQFOXLU
RWURVSDUiPHWURVGHFDUDDWLWXODUODÁXLGRWHUDSLDGHVRSRU-
WHYDVRDFWLYRRLQRWUySLFR48
6HSURSRQHTXHHVWRVVHDQ
DGHPiVGHOD)(GHOYHQWUtFXORL]TXLHUGR 9, HOiUHDGHO9,
HO97,DyUWLFR LQWHJUDOYHORFLGDGWLHPSRGHOÁXMRWUDQVDyU-
WLFR ODFRODSVDELOLGDGGHODYHQDFDYDLQIHULRUHOiUHDGH
ORVYHQWUtFXORVL]TXLHUGRGHUHFKRDOÀQDOGHODGLiVWROH
HYDOXDFLyQGHODIXQFLyQGLDVWyOLFDGHO9,PHGLDQWHHOHVWX-
GLRGHODVRQGDV(·H·6(VWRVMXQWRFRQSDUiPHWURVFOt-
QLFRVFRPRODIUHFXHQFLDFDUGLDFDODSUHVLyQDUWHULDO
VLVWyOLFDGLDVWyOLFDODGRVLVGHFDWHFRODPLQDVSXHGHQ
GLIHUHQFLDUIHQRWLSRVFDUGLRYDVFXODUHVPDFURKHPRGLQiPL-
cos en el shockVpSWLFRSDFLHQWHVFRQUHVXFLWDFLyQySWLPD
SDFLHQWHVFRQGLVIXQFLyQGHO9,SDFLHQWHVKLSHUFLQpWLFRV
SDFLHQWHVFRQGLVIXQFLyQGHOYHQWUtFXORGHUHFKRSDFLHQWHV
FRQKLSRYROHPLDSHUVLWHQWH
(VWDDSUR[LPDFLyQGLDJQyV-
WLFDFRQHFRFDUGLRJUDItDGHVGHHOLQLFLRGHOVRSRUWHDO
SDFLHQWHVpSWLFRVHKDHYDOXDGRFRPRODRSFLyQPDFURKH-
PRGLQiPLFDGHIXWXUR51
8QDGHODVOtQHDVDFWXDOHVGHLQYHV-
WLJDFLyQHVODUHVWULFFLyQGHODUHVXFLWDFLyQFRQÁXLGRVHQ
IDYRUGHOXVRSUHFR]GHFDWHFRODPLQDV52
SRUORTXHODHYD-
OXDFLyQPHGLDQWHHVWRVIHQRWLSRVSXHGHDXGDUHQODFDWH-
JRUL]DFLyQGHORVSDFLHQWHVHQHVWXGLRVTXHFRQGX]FDQD
XQDPHMRUDGHORVGHVHQODFHVFOtQLFRV1RVRORHOH[FHVRGH
ÁXLGRVJHQHUDUHVXOWDGRVDGYHUVRV53
VLQRTXHODDGPLQLVWUD-
FLyQPXSUHFR]GHYDVRFRQVWULFWRUHVQRLQGLFDGRVSXHGH
FRQGXFLUDXQDKLSRSHUIXVLyQWLVXODUVHFXQGDULDDYDVRFRQV-
WULFFLyQH[FHVLYD54
3RURWUDSDUWHODFRQJHVWLyQYHQRVDLQ-
GXFHDOWHUDFLRQHVHQORVSDWURQHVGHIOXMRYHQRVRHQORV
yUJDQRVDEGRPLQDOHVVHSXHGHHYDOXDUDSLHGHFDPDPH-
GLDQWHLPDJHQSRUHFRJUDItD'RSSOHU(VWDVDOWHUDFLRQHVVH
KDQDVRFLDGRGHPDQHUDFRQVLVWHQWHFRQODGLVIXQFLyQRUJi-
QLFDFRQJHVWLYDGHVHQODFHVFOtQLFRVDGYHUVRV55
(QFRQMXQ-
WRODHFRFDUGLRJUDItD'RSSOHUGHOVLVWHPDYHQRVRSRGUtDQ
VHUGHXWLOLGDGSDUDHVWDEOHFHUXQOtPLWHDODDGPLQLVWUDFLyQ
GHÁXLGRVHQODUHDQLPDFLyQLQLFLDOHQHWDSDVSRVWHULRUHV
GXUDQWHHOWUDWDPLHQWRKHPRGLQiPLFRGHODVHSVLV6LQHP-
EDUJRLQFOXVRFRQODHFRJUDItDODGLVIXQFLyQHQGRWHOLDOHO
DXPHQWRGHODSHUPHDELOLGDGYDVFXODUVXSRQHQXQUHWRLP-
SRUWDQWHGHELGRDTXHODYLGDPHGLDGHORVÁXLGRVDGPLQLV-
WUDGRVGLVPLQXHFRQVLGHUDEOHPHQWHODVDOWHUDFLRQHV
PDFURFLUFXODWRULDVYDORUDGDVSRUHFRJUDItDSRGUtDQVHUWUDQ-
VLWRULDVGXUDQWHWRGRHOSURFHVRTXHLPSOLFDODUHDQLPDFLyQ
KHPRGLQiPLFDHQVHSVLV
'HODPLRFDUGLRSDWtDDVRFLDGDDVHSVLVVHSXHGHGHVWDFDU
DOJXQDVGHÀQLFLRQHV/DGLVIXQFLyQVLVWyOLFDVHKDGHÀQLGR
HQWpUPLQRVGH)(6LQHPEDUJRHVWHSDUiPHWURUHTXLHUH
GHHYDOXDFLyQGLQiPLFDDQWHVGHHVWDEOHFHUHOGLDJQyVWLFR
7UDVXQDGHFXDGRYROXPHQGHUHVXFLWDFLyQHQVREUHYLYLHQWHV
de shockVpSWLFRVHREVHUYDXQDXPHQWRGHOJDVWRFDUGLDFR
HOGLiPHWURWHOHGLDVWyOLFRGHO9, '7'9, GLVPLQXFLyQGH
OD)(SDUDGyMLFDPHQWHHQFRPSDUDFLyQFRQORVQRVXSHUYL-
YLHQWHVHQORVTXHVHREVHUYDQEDMRV'7'9,DOWDV)(SRU
UHVXFLWDFLyQLQDGHFXDGDRVREUHHVWLPXODFLyQDGUHQpUJL-
FD/DGLODWDFLyQYHQWULFXODUODGLVPLQXFLyQGHOD)(FR-
UUHVSRQGHQDPHFDQLVPRVGHSURWHFFLyQYHQWULFXODUDO
HVWUpV56
/DGLVIXQFLyQGLDVWyOLFDVHFDUDFWHUL]DSRUXQGHWHULRURGH
ODUHODMDFLyQODGLVWHQVLELOLGDGGHO9,
(OHVWXGLRGHOD
IXQFLyQGLDVWyOLFDVHUHDOL]DPHGLDQWHGLYHUVDVWpFQLFDVGH
HYDOXDFLyQGHOOOHQDGRYHQWULFXODUDWUDYpVGH'RSSOHU
WUDQVPLWUDODVtFRPRHOJUDGRGHUHODMDFLyQDWUDYpVGHO
DQiOLVLVGHOPRYLPLHQWRSRU'RSSOHUWLVXODUDQLYHOGHODQLOOR
PLWUDOODWHUDOPHGLDO58
/DH[LVWHQFLDGHGLVIXQFLyQGLDVWy-
lica en pacientes con shockVpSWLFRVHDVRFLDFRQSHRUSUR-
QyVWLFR59
ODDSDULFLyQGHKLSHUWHQVLyQSXOPRQDUHQ
SDFLHQWHVFRQQHXPRQtDVtQGURPHGHGLVWUpVUHVSLUDWRULR
- 8. /KLVFDQR(3ODWD0HQFKDFD-5XL]5RGUtJXH]HWDO
DJXGR/DGLVIXQFLyQGLDVWyOLFDHVIDYRUHFLGDSRUHOHGHPD
PLRFiUGLFRFRQVHFXHQFLDGHODXPHQWRGHODSHUPHDELOLGDG
FDSLODUODH[WUDYDVDFLyQSURWHLFDWLVXODUORFXDODOWHUDOD
GLVWHQVLELOLGDGFDUGLDFD60
/DLQÁXHQFLDGHIDFWRUHVELROyJLFRVHVIXQGDPHQWDOHQOD
ÀVLRSDWRORJtDGHODGLVIXQFLyQYHQWULFXODUVHUHODFLRQDQFRQ
ODH[SRVLFLyQGHOPLRFLWRDP~OWLSOHVSURGXFWRVGHGLYHUVD
tQGROHSURGXFLGRVGXUDQWHHOSURFHVRLQÁDPDWRULRGDxRFH-
OXODU '$03 $VXYH]ORVSURFHVRVLQÁDPDWRULRVUHODFLRQD-
GRVFRQDJHQWHVLQIHFFLRVRVSXHGHQSRWHQFLDUHVWHIHQyPHQR
SRUPHGLRGHODSURGXFFLyQGH3$03
FRPRVRQHO/36HOiFL-
GROLSRWHLFKRLFRODÁDJHOLQDHO$'1EDFWHULDQRHOPDQDQR
HQKRQJRV$51YLUDOGHFDGHQDVLPSOHRGREOH
Alteraciones microcirculatorias en la sepsis
/DPLFURFLUFXODFLyQHVOD]RQDWHUPLQDOGHOWHMLGRYDVFXODU
FXRGLiPHWURHV—P/DVDUWHULRODVODVYHQDVSRVFD-
SLODUHVFDSLODUHVYpQXODVVHHQFDUJDQGHODWUDQVIHUHQFLD
GHR[tJHQRODUHJXODFLyQGHOLQWHUFDPELRGHVROXWRVHO
WUDQVSRUWHKRUPRQDOODWUDQVIHUHQFLDGHQXWULHQWHV/DV
DOWHUDFLRQHVHQHVWHVLVWHPDLQGXFLGDVSRUODVHSVLVFRUUHV-
SRQGHQDXQDGLVPLQXFLyQHQODGHQVLGDGFDSLODUXQDDOWH-
UDFLyQHQODSHUIXVLyQGHODPLFURYDVFXODWXUD(VWiQ
LPSOLFDGDVODGLVIXQFLyQHQGRWHOLDOODFRPXQLFDFLyQFHOXODU
ODDGKHVLYLGDGLQWHUFHOXODU
/DUHVXFLWDFLyQGHOshockVpSWLFRVHKDEDVDGRFRQYHQFLR-
QDOPHQWHHQFRUUHJLUODVDOWHUDFLRQHVGHODPDFURFLUFXODFLyQ
DWUDYpVGHYDULDEOHVFRPRODUHVSXHVWDDODLQIXVLyQGHFULV-
taloides63
RHOVRSRUWHYDVRDFWLYR64
6LQHPEDUJRH[LVWHHYL-
GHQFLDH[SHULPHQWDOFOtQLFDTXHUHODFLRQDHOGHWHULRURGHOD
PLFURFLUFXODFLyQFRQODGLVIXQFLyQRUJiQLFDODPRUWDOLGDG65
(QSDUDOHORDODVDOWHUDFLRQHVPDFURFLUFXODWRULDVTXHKDQ
VLGRREMHWRGHHVWXGLRHQHOFRQFHSWR“early goal-directed
therapy”66
H[LVWHQDOWHUDFLRQHVPLFURFLUFXODWRULDVTXHDIHF-
WDQDODSHUIXVLyQHVWiQUHODFLRQDGDVFRQHOGHVDUUROORGH
GLVIXQFLyQPXOWLRUJiQLFDPRUWDOLGDG'HODPLVPDPDQHUD
TXHHQHOshockGLVWULEXWLYRGHRULJHQVpSWLFRHVWDVDOWHUD-
FLRQHVVHKDQGHVFULWRHQHOVtQGURPHGHUHVSXHVWDLQÁDPDWR-
ULD VLVWpPLFD VHFXQGDULR D shock FDUGLRJpQLFR
KHPRUUiJLFR69
FLUXJtDPDRU
FOiVLFDPHQWHODFLUXJtDFDU-
diaca)
/RVPRGHORVH[SHULPHQWDOHVKDQPRVWUDGRTXHODVDOWHUD-
FLRQHVTXHODVHSVLVRFDVLRQDHQHOVLVWHPDPLFURYDVFXODU
VRQODGLVPLQXFLyQGHODFDSLODULGDGVXGHQVLGDG
y la va-
ULDELOLGDGHQODSHUIXVLyQ
(VWRVPRGHORVVHKDQHVWXGLDGR
HQGLIHUHQWHVVLWXDFLRQHVPHGLDQWHODDGPLQLVWUDFLyQGHHQ-
GRWR[LQDHOHIHFWRVHKDHYDOXDGRHQGLIHUHQWHVWHMLGRV
FRPRODSLHO
ODOHQJXDHOWHMLGRHVSOiFQLFR
HOKtJDGRR
LQFOXVRWHMLGRFHUHEUDO
'HELGRDTXHODDOWHUDFLyQHQODPLFURFLUFXODFLyQHVSULQ-
FLSDOPHQWHDGDSWDWLYDHVLPSRUWDQWHLQYHVWLJDUFyPROD
VHSVLVSXHGHOOHJDUDSURGXFLUHVWRVFDPELRV(QFRQGLFLRQHV
H[SHULPHQWDOHVVHKDGHPRVWUDGRTXHODKLSR[LDWLVXODU
GHÀQLGDSRUSUHVLyQSDUFLDOGHR[tJHQRGLVPLQXLGDHQSUH-
VHQFLDGHUHDFFLRQHVFRQDFWLYLGDGredox, SURGXFHKLSRSHU-
IXVLyQHQHOWHMLGR/DGLUHFFLyQGHHVWDUHDFFLyQHVHQHVWH
VHQWLGRQRDOUHYpVHQWDQWRTXHORSULPDULRHVODKLSR[LD
QRODKLSRSHUIXVLyQ
(QHVWXGLRVUHDOL]DGRVHQODPLFURFLU-
FXODFLyQVXEOLQJXDOVHKDGHPRVWUDGRTXHXQDPHMRUtDGHOD
KLSR[LDWLVXODUFRQGXFHDXQDPHMRUtDGHODSHUIXVLyQ
(V
IiFLODVXPLUHQWRQFHVTXHODPHMRUR[LJHQDFLyQHVWiUHOD-
FLRQDGDFRQODPHMRUtDHQODPLFURFLUFXODFLyQHVWDDVX
YH]FRQODVXSHUYLYHQFLD80
/DDGDSWDFLyQGHOWHMLGRPLFURYDVFXODUGHVXMHWRVVDQRV
VHSURGXFHSULQFLSDOPHQWHSRUPHFDQLVPRVODDFFLyQGHO
VLVWHPDVLPSiWLFRSHULYDVFXODUODFpOXODHQGRWHOLDO81
$GH-
PiVORVKHPDWtHV82
SXHGHQOOHJDUDIXQFLRQDUFRPRVHQVRUHV
LQWUDYDVFXODUHVGHWDOIRUPDTXHODGLVPLQXFLyQGHODFRQ-
FHQWUDFLyQGHODVDWXUDFLyQGHR[tJHQRLQGXFHOLEHUDFLyQGH
12ODFRQVLJXLHQWHGLODWDFLyQFDSLODU(QODVHSVLVORVPH-
FDQLVPRVLPSOLFDGRVHQODPLFURFLUFXODFLyQPiVDOOiGHOD
GLVIXQFLyQHQGRWHOLDOVRQHOGHVHTXLOLEULRGHODKRPHRVWDVLV
HQWUHVXVWDQFLDVYDVRFRQVWULFWRUDVYDVRGLODWDGRUDVOD
DOWHUDFLyQGHJOXFRFiOL]7POHWDO83
ORKDQGHPRVWUDGRVL-
PXODQGRXQVtQGURPHGHUHSHUIXVLyQHQPRGHORVH[SHUL-
PHQWDOHV(VWRVHVWXGLRVWDPELpQVHKDQOOHYDGRDFDERHQ
SDFLHQWHVVpSWLFRVODSUHVHQFLDGHGLVIXQFLyQHQGRWHOLDO
VHKDUHODFLRQDGRFRQODJUDYHGDGGHODGLVIXQFLyQRUJiQL-
ca84
ORVGHVHQODFHVFOtQLFRV85
.
(QODVHSVLVODLQWHUDFFLyQHQWUHODVXSHUÀFLHHQGRWHOLDO
ODVFpOXODVFLUFXODQWHVWDPELpQVHHQFXHQWUDDOWHUDGD(O
JURVRUGHOJOXFRFiOL]HVWiSURIXQGDPHQWHDOWHUDGRDVtFRPR
VXVSURSLHGDGHVUHJXODGRUDVSDUDODLQWHUDFFLyQFHOXODUTXH
OLEHUDVXVWDQFLDVQHFHVDULDVSDUDHOPHWDEROLVPR
/DDF-
WLYDFLyQGHODFRDJXODFLyQWDPELpQDOWHUDODKRPHRVWDVLV
FDSLODUODGLIXVLyQ88
GHOR[tJHQRHQWUHORVWHMLGRV)LQDO-
PHQWHODDGKHVLyQFHOXODUDHVWHWHMLGRGDxDGRKDFHXQ
SDSHOLPSRUWDQWH(OIHQyPHQRGHrolling, tanto de leucoci-
WRVFRPRGHSODTXHWDVVHHQFXHQWUDDXPHQWDGRHQHOSD-
FLHQWHVpSWLFRORTXHSRWHQFLDD~QPiVODFDVFDGD
LQÁDPDWRULD$GHPiVHOSULQFLSDODFWRUGHODR[LJHQDFLyQ
WLVXODUHOKHPDWtHVHGHIRUPDSRUODVDOWHUDFLRQHVHQOD
SDUHGHQGRWHOLDO89
FRQORFXDOGLVPLQXHODHIHFWLYLGDGGH
HVWDFpOXODSDUDODVHFUHFLyQWDQWRGH12FRPRGHR[tJHQR
(VWRSURORQJDHOGHVDMXVWHHQWUHSHUIXVLyQR[LJHQDFLyQ90
Coherencia hemodinámica
(QHVWHVHQWLGR,QFHHWDOSURSRQHQFyPRRSWLPL]DUHOYR-
OXPHQGHÁXLGRSDUDPD[LPL]DUODFDSDFLGDGGHODPLFURFLU-
FXODFLyQSDUDWUDQVSRUWDUR[tJHQRDORVWHMLGRV(OFRQFHSWR
GH´FRKHUHQFLDKHPRGLQiPLFDµVHUHÀHUHDTXHHOWUDWD-
PLHQWRJHQHUDOKDELWXDOSDUDHOshockVHEDVDHQPHMRUDUHO
ÁXMRFDSLODU
6LQHPEDUJRDSHVDUGHXQÁXMRFDSLODU
QRUPDOHOWUDQVSRUWHSXHGHVHULQHÀFD]SRUODH[LVWHQFLDGH
DOWHUDFLRQHVGHODGLIXVLyQGHQXWULHQWHVR[tJHQR/RVWLSRV
GHSpUGLGDGHFRKHUHQFLDKHPRGLQiPLFDVHFODVLILFDQHQ
JUXSRV ÀJXUD KHWHURJHQHLGDGHQODSHUPHDELOLGDGFD-
SLODUGHQWURGHOPLVPRWHMLGRKHPRGLOXFLyQTXHLQFUHPHQ-
WDODGLÀFXOWDGSDUDODGLIXVLyQGHVXVWDQFLDVDXPHQWRGH
UHVLVWHQFLDVYDVFXODUHVLQGXFLGDVXREVWUXFFLyQDOÁXMRGH
UHWRUQRYHQRVRHGHPDWLVXODUVHFXQGDULRDODXPHQWRGH
SHUPHDELOLGDGFDSLODUFRQGLIXVLyQGHVXVWUDWRVDIHFWDGD
(OREMHWLYRGHOWUDWDPLHQWRGHEHVHUUHVWDEOHFHUODFRKH-
UHQFLDKHPRGLQiPLFD3RUORWDQWRORVIXWXURVHVWXGLRVGH-
EHQWHQHUHVWHDVSHFWRFRPRREMHWLYRFHQWUiQGRVHHQORV
HIHFWRVÀVLRSDWROyJLFRVHQODPLFURFLUFXODFLyQ8QDHVWUDWH-
JLDEDVDGDHQODDGPLQLVWUDFLyQGHDJHQWHVYDVRSUHVRUHVH
LQRWUySLFRVWUDQVIXVLyQGHKHPRGHULYDGRVQRWHQGUiHO
PHMRUUHVXOWDGRVLQRVHORJUDPHMRUDUPDQWHQHUHOÁXMR
HQHOWHUULWRULRPLFURYDVFXODU92
(VWHDVSHFWRVHKDGHPRV-
- 9. Medicina Intensiva 46S1 (2022):1-13 9
WUDGRHQHQVDRVFOtQLFRV93
'XELQHWDOGHPRVWUDURQTXHHO
DXPHQWRGHODSUHVLyQDUWHULDOPHGLDSRUHQFLPDGH
PP+JFRQGRVLVFUHFLHQWHVGHQRUDGUHQDOLQDSXHGHPH-
MRUDUHOJDVWRFDUGLDFRODSUHVLyQSXOPRQDUODVUHVLVWHQFLDV
YDVFXODUHVVLVWpPLFDVORVGLYHUVRVSDUiPHWURVPDFURKHPR-
GLQiPLFRV6LQHPEDUJRHVWRQRHVFDSD]GHPHMRUDUODSHU-
IXVLyQPLFURYDVFXODUHLQFOXVRSXHGHVHUSHUMXGLFLDO94
OR
FXDOORFRQYLHUWHHQXQIDFWRUSURQyVWLFR95
(OUHFOXWDPLHQWR
GHODPLFURFLUFXODFLyQVHUHODFLRQDFRQODPHMRUtDGHODIXQ-
FLyQRUJiQLFD96
(QORV~OWLPRVDxRVODDWHQFLyQDODUHVSXHVWDPLFURYDV-
FXODUVHKDFHQWUDGRHQODVLQWHUYHQFLRQHVIDUPDFROyJLFDV
FRQODHVSHUDQ]DGHHQFRQWUDUWUDWDPLHQWRVFDSDFHVGHUHV-
WDXUDUHOÁXMRPLFURFLUFXODWRULR/DVHOHFFLyQDGHFXDGDGH
ORVSDFLHQWHVSDUDHVWHWLSRGHLQWHUYHQFLRQHVHVIXQGDPHQ-
WDO$SLHGHFDPDODVDOWHUDFLRQHVFRPRODSLHOPRWHDGDHO
WLHPSRGHOOHQDGRFDSLODUSURORQJDGRRHOJUDGLHQWHGHWHP-
SHUDWXUDGHFHQWUDODSHULIpULFDVRQPDQLIHVWDFLRQHVFOtQL-
FDVIUHFXHQWHVGHODDOWHUDFLyQHQODPLFURFLUFXODFLyQ
(VWRVSDUiPHWURVVHFRUUHODFLRQDQFRQODJUDYHGDGGHODGLV-
IXQFLyQRUJiQLFDSUHGLFHQODPRUWDOLGDG7DPELpQSXHGHQ
FRQVWLWXLUXQDJXtDGHWUDWDPLHQWR(OUHOOHQRFDSLODUVH
SXHGHXWLOL]DUSDUDJXLDUODUHVXFLWDFLyQ98
+DDXWRUHVTXHLQFOXVRSURPXOJDQGHMDUGHODGRORVREMH-
WLYRVPDFURKHPRGLQiPLFRVSDUDFHQWUDUVHHQODPLFURFLUFX-
ODFLyQ99
(VWXGLRVH[SHULPHQWDOHVPXHVWUDQTXHODVWHUDSLDV
YDVRGLODWDGRUDVSXHGHQVHU~WLOHVHQHOWUDWDPLHQWRGHODV
DOWHUDFLRQHVGHODPLFURFLUFXODFLyQ100
(QSDFLHQWHVFRQ
shockVpSWLFR'H%DFNHUHWDO80
GHPRVWUDURQFRPRODDGPL-
QLVWUDFLyQWySLFDGHDFHWLOFROLQDXQDJHQWHYDVRGLODWDGRU
HQGRWHOLDOUHVWDXUDODPLFURFLUFXODFLyQVXEOLQJXDOORTXH
LQGLFDXQSRVLEOHEHQHÀFLRGHODVWHUDSLDVYDVRGLODWDGRUDV
(VWRVKDOOD]JRVDSXQWDQDTXHHOIHQyPHQRGHYDVRFRQVWULF-
FLyQLQDSURSLDGDSXHGHVHUSHUMXGLFLDOFRQVWLWXLUXQDQXH-
YDGLDQDWHUDSpXWLFD101
(OHIHFWRYDVRGLODWDGRUGHOD
GREXWDPLQDSXHGHUHVXOWDUGHXWLOLGDGFRPRPHGLGDSDUD
UHFOXWDUODPLFURFLUFXODFLyQ102
7DPELpQVHKDQREWHQLGRUH-
VXOWDGRVSURPHWHGRUHVFRQDQiORJRVGHODSURVWDFLFOLQD
TXHVRQSRWHQWHVYDVRGLODWDGRUHVDUWHULRODUHVTXHSXHGHQ
FXPSOLUHOFULWHULRGHDFWXDUSUHGRPLQDQWHPHQWHHQODUHG
SUHFDSLODU6LQHPEDUJRWDPELpQKDGDWRVFRQWUDGLFWRULRV
(QXQHQVDRDOHDWRUL]DGRODDGPLQLVWUDFLyQGHQLWURJOLFHUL-
na en shockVpSWLFRQRREWXYREHQHÀFLR105
([LVWHQGLYHUVDVHVWUDWHJLDVSDUDVHOHFFLRQDUDORVSDFLHQ-
WHVFDQGLGDWRVDHVWRVWUDWDPLHQWRVDVtFRPRSDUDPRQLWR-
UL]DUODUHVSXHVWDDHVWRV106
3RUXQDSDUWHODH[SORUDFLyQ
FOtQLFD PRWHDGRHQSLHOJUDGLHQWHGHWHPSHUDWXUD WLHQH
ODYHQWDMDGHTXHQRUHTXLHUHWHFQRORJtDHVUiSLGDPHQWH
DSOLFDEOH6LQHPEDUJRGHSHQGHGHOREVHUYDGRUVHOLPLWD
DODREVHUYDFLyQGHODSLHO/DYLGHRPLFURVFRSLDTXHYDORUD
WDQWRHOÁXMRPLFURYDVFXODUFRPRODGHQVLGDGFDSLODUOD
KHWHURJHQHLGDGGHODSHUIXVLyQHVDFWXDOPHQWHHOSDWUyQ
GHUHIHUHQFLDSDUDHOGLDJQyVWLFR6HDSOLFDDSLHGHFDPD
DXQTXHUHTXLHUHH[SHULHQFLDSUHYLDORVUHVXOWDGRVQRHV-
WiQGLVSRQLEOHVLQPHGLDWDPHQWH
/DPLFURFLUFXODFLyQ
WDPELpQVHSXHGHHYDOXDUGHPDQHUDLQGLUHFWD/DPHGLFLyQ
GHODSUHVLyQSDUFLDOGHGLy[LGRGHFDUERQRWLVXODU PHGLDQ-
WHFDSQRPHWUtDVXEOLQJXDORJiVWULFD LQIRUPDVREUHHOHVWD-
GRPHWDEyOLFRVHSXHGHDSOLFDUDODFDEHFHUDGHOSDFLHQWH
DXQTXHHVXQDWpFQLFDFRPSOHMD/DSUXHEDGHRFOXVLyQGH
XQDH[WUHPLGDGSHUPLWHPHGLDQWHHOHFWURGRVWUDQVFXWi-
QHRVPHGLUODSUHVLyQSDUFLDOGHR[tJHQR6LQHPEDUJRDO
VHUXQDPHGLGDGHULYDGDGHODPLFURYDVFXODWXUDSXHGHWH-
QHUUHVXOWDGRVGLVSDUHVDOHYDOXDUGLIHUHQWHVWHUULWRULRVFRQ
Figura 3 $OWHUDFLRQHVGHODPLFURFLUFXODFLyQDVRFLDGDVFRQODSpUGLGDGHODFRKHUHQFLDKHPRGLQiPLFD/DVDOWHUDFLRQHVTXH
FRQOOHYDQODSpUGLGDGHODFRKHUHQFLDKHPRGLQiPLFDFRQGXFHQDKLSR[LDWLVXODU+HWHURJHQHLGDGFDSLODUODSUHVHQFLDGHFDSLODUHV
SHUPHDEOHVDOODGRGHRWURVREWXUDGRVUHVXOWDHQXQDR[LJHQDFLyQKHWHURJpQHDGHOWHMLGR+HPRGLOXFLyQODUHVXFLWDFLyQOOHYDDOD
KHPRGLOXFLyQHOORKDFHTXHKDDPHQRUSURSRUFLyQGHKHPDWtHVSRUORTXHKDPHQRUSURSRUFLyQGHWUDQVSRUWHGHR[tJHQR
RQVWULFFLyQWDSRQDPLHQWRODVVXVWDQFLDVLQÁDPDWRULDVDOWHUDQODUHJXODFLyQGHOWRQRYDVFXODUTXHDOWHUDHOÁXMRFDSLODUSRU
HQGHJHQHUDDQRUPDOLGDGHVGHODSUHVLyQKLGURVWiWLFDRQFyWLFDTXHFRQOOHYDQXQDDOWHUDFLyQHQODGLIXVLyQGHOR[tJHQRWLVXODU
(GHPDVHFXQGDULRDXQDVLWXDFLyQGHIXJDFDSLODUDFDEDSRUHPSHRUDUHOWUDQVSRUWHGHR[tJHQRSRUDOWHUDFLyQGHODFRUUHFWD
FLUFXODFLyQGHOKHPDWtH
- 11. Medicina Intensiva 46S1 (2022):1-13 11
Bibliografía
6LQJHU0'HXWVFKPDQ66HPRXU:6KDQNDU+DUL0$QQDQH
'%DXHU0HWDO7KH7KLUG,QWHUQDWLRQDORQVHQVXV'HÀQLWLRQV
IRU6HSVLVDQG6HSWLF6KRFN 6HSVLV JAMA
KHQ*1XxH]*6WHULOHLQÁDPPDWLRQVHQVLQJDQGUHDFWLQJ
WRGDPDJHNat Rev Immunol
%DX]i0DUWLQH]-$OHWWL)3LQWR%%5LEDV92GHQD0$'tD]
5HWDO3URWHROVLVLQVHSWLFVKRFNSDWLHQWVSODVPDSHSWLG-
RPLFSDWWHUQVDUHDVVRFLDWHGZLWKPRUWDOLWBr J Anaesth
KRXVWHUPDQ%*6ZLUVNL).:HEHU*)WRNLQHVWRUPDQG
VHSVLV GLVHDVH SDWKRJHQHVLV Semin Immunopathol.
5XELR,2VXFKRZVNL0)6KDQNDU+DUL06NLUHFNL7:LQNOHU
06/DFKPDQQ*HWDOXUUHQWJDSVLQVHSVLVLPPXQRORJ
QHZRSSRUWXQLWLHVIRUWUDQVODWLRQDOUHVHDUFKLancet Infect
DisHH
7DQJ%0+XDQJ6-0F/HDQ$6*HQRPHZLGHWUDQVFULSWLRQ
SURÀOLQJRIKXPDQVHSVLVDVVWHPDWLFUHYLHZCrit Care
5
7DPDR()HUQiQGH]$$OPDQVD5DUUDVFR(+HUHGLD0
/DMRHWDO3URDQGDQWLLQÁDPPDWRUUHVSRQVHVDUHUHJX-
ODWHGVLPXOWDQHRXVOIURPWKHÀUVWPRPHQWVRIVHSWLFVKRFN
Eur Cytokine Netw
/RUHQWH6RUROOD*DUFLD*RPH]$DWDOj0ROO)7ROHGDQR9
LXGDG/$YHQGDxR2UWL]-HWDO,QÁDPPDWRUFWRNLQHVDQG
RUJDQGVIXQFWLRQDVVRFLDWHZLWKWKHDEHUUDQW'1$PHWKORPH
RIPRQRFWHVLQVHSVLVGenome Med
0DQWKRXV$+DOO-%6DPVHO5:(QGRWR[LQLQKXPDQGLVHDVH
3DUW%LRORJLFHIIHFWVDQGFOLQLFDOHYDOXDWLRQVRIDQWLHQGRWR-
[LQWKHUDSLHVChest.
6WHSKHQV50WKHQ0(QGRWR[LQLPPXQL]DWLRQIntensive
Care Med.6XSSO6
=DQRQL,2VWXQL50DUHN/5%DUUHVL6%DUEDODW5%DUWRQ*0
HWDO'FRQWUROVWKH/36LQGXFHGHQGRFWRVLVRI7ROOOLNH
UHFHSWRUCell
RKHQ - 7KH LPPXQRSDWKRJHQHVLV RI VHSVLV Nature
(VWHEDQ()HUUHU5$OVLQD/$UWLJDV$,PPXQRPRGXODWLRQLQ
VHSVLVWKHUROHRIHQGRWR[LQUHPRYDOESROP[LQ%LPPREL-
OL]HGFDUWULGJH0HGLDWRUV,QÁDPP
+RWFKNLVV560ROGDZHU//2SDO605HLQKDUW.7XUQEXOO,5
9LQFHQW-/6HSVLVDQGVHSWLFVKRFNNat Rev Dis Primers
'ULIWH*'XQQ6LHJULVW,7LVVLqUHV33XJLQ-,QQDWHLPPXQH
IXQFWLRQVRILPPDWXUHQHXWURSKLOVLQSDWLHQWVZLWKVHSVLVDQG
VHYHUHVVWHPLFLQÁDPPDWRUUHVSRQVHVQGURPHCrit Care
Med
1LHUKDXV$.ODWWH6/LQVVHQ-(LVPDQQ10:LFKPDQQ'+H-
GNH-HWDO5HYLVLWLQJWKHZKLWHEORRGFHOOFRXQWLPPDWXUH
JUDQXORFWHVFRXQWDVDGLDJQRVWLFPDUNHUWRGLVFULPLQDWHEHW-
ZHHQ6,56DQGVHSVLV³DSURVSHFWLYHREVHUYDWLRQDOVWXG
BMC Immunol
R[/(:DOVWHLQ.9|OOJHU/5HXQHU)%LFN$'|WVFK$HWDO
1HXWURSKLOH[WUDFHOOXODUWUDSIRUPDWLRQDQGQXFOHDVHDFWLYLW
LQVHSWLFSDWLHQWVBMC Anesthesiol
DPLFLD*3R]QHU5GH/DUUDxDJD*1HXWURSKLOH[WUDFHOOXODU
WUDSVLQVHSVLVShock
'DL[7*XHULQ(7DYHUQLHU(0HUFLHU(*LVVRW9+pUDXOW2HW
DO0XOWLFHQWULFVWDQGDUGL]HGÁRZFWRPHWUURXWLQHDVVHVV-
PHQWRISDWLHQWVZLWKVHSVLVWRSUHGLFWFOLQLFDOZRUVHQLQJ
Chest
'HQN67DORU53
:LHJQHU5RRN(0/LQGRUIHU0$3IHLIIHU.
HWDORPSOHPHQWDLQGXFHGFKDQJHVLQQHXWURSKLOPRUSKRO-
RJGXULQJLQÁDPPDWLRQScand J Immunol
DEUHUD3HUH]-RQGRWWD6$-DPHV%5.DVKHP6:%ULQFNV
(/5DL'HWDO$OWHUDWLRQVLQDQWLJHQVSHFLÀFQDLYH'7FHOO
SUHFXUVRUVDIWHUVHSVLVLPSDLUVWKHLUUHVSRQVLYHQHVVWRSDWKR-
JHQFKDOOHQJHJ Immunol
0DUWLQ/RHFKHV,0XULHO%RPEtQ$)HUUHU5$UWLJDV$6ROH
9LRODQ-/RUHQWH/HWDO7KHSURWHFWLYHDVVRFLDWLRQRIHQGR-
JHQRXVLPPXQRJOREXOLQVDJDLQVWVHSVLVPRUWDOLWLVUHVWULFWHG
WRSDWLHQWVZLWKPRGHUDWHRUJDQIDLOXUHAnn Intensive Care
'HXWVFKPDQ6+HOOPDQ-)HUUHU5RFD5'H%DFNHU'RR-
SHUVPLWK07KH6XUYLYLQJ6HSVLVDPSDLJQ%DVLF7UDQVODWLR-
QDO6FLHQFH5HVHDUFK3ULRULWLHVCrit Care Med
%HUPHMR0DUWLQ-)$QGDOX]2MHGD'$OPDQVD5*DQGtD)
*yPH]+HUUHUDV-,*RPH]6DQFKH](HWDO'HÀQLQJLPPXQR-
ORJLFDOGVIXQFWLRQLQVHSVLV$UHTXLVLWHWRROIRUSUHFLVLRQ
PHGLFLQHJ Infect
-DFNVRQ63
'DUERXVVHW56FKRHQZDHOGHU607KURPERLQÁDP-
PDWLRQFKDOOHQJHVRIWKHUDSHXWLFDOOWDUJHWLQJFRDJXODWLRQDQG
RWKHUKRVWGHIHQVHPHFKDQLVPVBlood
YDQGHU3ROO7+HUZDOG+7KHFRDJXODWLRQVVWHPDQGLWVIXQFWLRQ
LQHDUOLPPXQHGHIHQVHThromb Haemost
7DORU)%-U7RK++RRWV:.:DGD+/HYL07RZDUGVGHÀ-
QLWLRQFOLQLFDODQGODERUDWRUFULWHULDDQGDVFRULQJVVWHP
IRUGLVVHPLQDWHGLQWUDYDVFXODUFRDJXODWLRQThromb Haemost
3UHQWLFH5$FTXLUHGFRDJXODWLRQGLVRUGHUVClin Haematol
:DUNHQWLQ7(0LFURYDVFXODUWKURPERVLVDQGLVFKDHPLFOLPEORV-
VHVLQFULWLFDOOLOOSDWLHQWVHamostaseologie
'HODEUDQFKH;+HOPV-0H]LDQL),PPXQRKDHPRVWDVLVD
QHZYLHZRQKDHPRVWDVLVGXULQJVHSVLVAnn Intensive Care
‘VWHUXG%%M¡UNOLG(7KHWLVVXHIDFWRUSDWKZDLQGLVVHPLQD-
WHG LQWUDYDVFXODU FRDJXODWLRQ Semin Thromb Hemost
/XSX).HVKDUL56/DPEULV-'RJJHVKDOO.0URVVWDONEHW-
ZHHQWKHFRDJXODWLRQDQGFRPSOHPHQWVVWHPVLQVHSVLV
Thromb Res6XSSO66
,ED70LNL7+DVKLJXFKL17DEH1DJDRND,,VWKHQHXWURSKLO
D¶SULPDGRQQD·LQWKHSURFRDJXODQWSURFHVVGXULQJVHSVLVCrit
Care
6HPHUDUR1$PPROOR76HPHUDUR)ROXFFL06HSVLVWKURP-
ERVLVDQGRUJDQGVIXQFWLRQThromb Res
/RUHQWH/0DUWtQ006ROp9LROiQ-%ODQTXHU-/DEDUWD/
'tD]HWDO$VVRFLDWLRQRIVHSVLVUHODWHGPRUWDOLWZLWKHDUO
LQFUHDVHRI7,03003UDWLRPLoS One H
=HHUOHGHU66FKURHGHU9+DFN(.RKOHU+3
:XLOOHPLQ:$7$),
DQG3$,OHYHOVLQKXPDQVHSVLVThromb Res
0DYURPPDWLV$7KHRGRULGLV7(FRQRPRX0.RWDQLGRX$(O
$OL0KULVWRSRXORX.RNNLQRX9HWDO$FWLYDWLRQRIWKHÀEUL-
QROWLFVVWHPDQGXWLOL]DWLRQRIWKHFRDJXODWLRQLQKLELWRUVLQ
VHSVLVFRPSDULVRQZLWKVHYHUHVHSVLVDQGVHSWLFVKRFNInten-
sive Care Med
*ULIÀQ-+=ORNRYLF%90RVQLHU/23URWHLQDQWLFRDJXODQWDQG
FWRSURWHFWLYHSDWKZDVInt J Hematol
,ED7/HY-+,QÁDPPDWLRQDQGWKURPERVLVUROHVRIQHXWUR-
SKLOVSODWHOHWVDQGHQGRWKHOLDOFHOOVDQGWKHLULQWHUDFWLRQVLQ
WKURPEXV IRUPDWLRQ GXULQJ VHSVLV J Thromb Haemost
/ySH]$JXLUUH3iUDPR-$(QGRWKHOLDOFHOODQGKHPRVWDWLF
DFWLYDWLRQLQUHODWLRQWRFWRNLQHVLQSDWLHQWVZLWKVHSVLV
Thromb Res
%HUPHMR0DUWLQ-)0DUWtQ)HUQDQGH]0/ySH]0HVWDQ]D
'XTXH3$OPDQVD56KDUHGIHDWXUHVRIHQGRWKHOLDOGV-
IXQFWLRQEHWZHHQVHSVLVDQGLWVSUHFHGLQJULVNIDFWRUV DJLQJ
DQGFKURQLFGLVHDVH J Clin Med
.LWFKHQV67KURPERFWRSHQLDDQGWKURPERVLVLQGLVVHPLQD-
WHGLQWUDYDVFXODUFRDJXODWLRQ ', Hematology Am Soc He-
matol Educ Program
- 12. 12 /KLVFDQR(3ODWD0HQFKDFD-5XL]5RGUtJXH]HWDO
0DJGHU69ROXPHDQGLWVUHODWLRQVKLSWRFDUGLDFRXWSXWDQG
YHQRXVUHWXUQCrit Care
+HVV0/+DVWLOOR$*UHHQÀHOG/-6SHFWUXPRIFDUGLRYDVFXODU
IXQFWLRQGXULQJJUDPQHJDWLYHVHSVLVProg Cardiovasc Dis.
3DUNHU006KHOKDPHU-+%DFKDUDFK6/*UHHQ091DWDQVRQ
)UHGHULFN70HWDO3URIRXQGEXWUHYHUVLEOHPRFDUGLDOGH-
SUHVVLRQ LQ SDWLHQWV ZLWK VHSWLF VKRFN Ann Intern Med
:LOVRQ5)
KLVFDQR$'4XDGURV(7DUYHU06RPHREVHUYDWLRQVRQ
SDWLHQWVZLWKVHSWLFVKRFNAnesth Analg
'H%DFNHU'%DNNHU-HFFRQL0+DMMDU//LX':/RER6HW
DO$OWHUQDWLYHVWRWKH6ZDQ*DQ]FDWKHWHU Intensive Care
Med
3HUQHU$HFFRQL0URQKMRUW0'DUPRQ0-DNRE603HWWL-
Ol9HWDO([SHUWVWDWHPHQWIRUWKHPDQDJHPHQWRIKSRYROH-
PLDLQVHSVLVIntensive Care Med
*HUL*9LJQRQ3$XEU$)HGRX$/KDUURQ6LOYD6HWDO
DUGLRYDVFXODUFOXVWHUVLQVHSWLFVKRFNFRPELQLQJFOLQLFDODQG
HFKRFDUGLRJUDSKLFSDUDPHWHUVDSRVWKRFDQDOVLVIntensive
Care Med
'DXODVLP$9LHLOODUG%DURQ$*HUL*+HPRGQDPLFFOLQLFDOSKH-
QRWSLQJLQVHSWLFVKRFNCurr Opin Crit Care
RRSHUVPLWK0'H%DFNHU''HXWVFKPDQ6)HUUHU5/DW,
0DFKDGR)5HWDO6XUYLYLQJ6HSVLVDPSDLJQUHVHDUFKSULRULWLHV
IRUVHSVLVDQGVHSWLFVKRFNCrit Care Med
0DFGRQDOG63-.HLM]HUV*7DORU'0.LQQHDU)$UHQGWV*
)DWRYLFK'0HWDO5HVWULFWHGÁXLGUHVXVFLWDWLRQLQVXVSHFWHG
VHSVLVDVVRFLDWHGKSRWHQVLRQ 5()5(6+ DSLORWUDQGRPLVHG
FRQWUROOHGWULDOIntensive Care Med.
3HUQHU$9LHLOODUG%DURQ$%DNNHU-)OXLGUHVXVFLWDWLRQLQ,8
SDWLHQWVTXRYDGLVIntensive Care Med
0XUDNDZD..REDDVKL$(IIHFWVRIYDVRSUHVVRUVRQUHQDOWLV-
VXHJDVWHQVLRQVGXULQJKHPRUUKDJLFVKRFNLQGRJVCrit Care
Med
$UJDL](59([861H[XVEHGVLGHDVVHVVPHQWRIYHQRXVFRQJHV-
WLRQAdv Chronic Kidney Dis
9LQFHQW-/0DUVKDOO-1DPHQGV6LOYD6$)UDQoRLV%0DU-
WLQ/RHFKHV,/LSPDQ-HWDO$VVHVVPHQWRIWKHZRUOGZLGH
EXUGHQRIFULWLFDOLOOQHVVWKHLQWHQVLYHFDUHRYHUQDWLRQV
,21 DXGLWLancet Respir Med
6XiUH]-/ySH]30DQFHER-=DSDWD/'LDVWROLFGVIXQFWLRQ
LQWKHFULWLFDOOLOOSDWLHQWMed Intensiva
1DJXHK6)6PLVHWK2$$SSOHWRQ3%UG%)UG'RNDLQLVK+
(GYDUGVHQ7HWDO5HFRPPHQGDWLRQVIRUWKHHYDOXDWLRQRIOHIW
YHQWULFXODUGLDVWROLFIXQFWLRQEHFKRFDUGLRJUDSKDQXSGDWH
IURPWKH$PHULFDQ6RFLHWRI(FKRFDUGLRJUDSKDQGWKH(XUR-
SHDQ$VVRFLDWLRQRIDUGLRYDVFXODU,PDJLQJJ Am Soc Echocar-
diogr
6DQÀOLSSR)RUUHGRU)OHWFKHU1/DQGHVEHUJ*%HQHGHWWR
8)RH[3HWDO'LDVWROLFGVIXQFWLRQDQGPRUWDOLWLQVHSWLF
SDWLHQWVDVVWHPDWLFUHYLHZDQGPHWDDQDOVLVIntensive
Care Med
KDJQRQ)%HQWRXUNLD0/HFRPWH5/HVVDUG0/HVXU2(Q-
GRWR[LQLQGXFHGKHDUWGVIXQFWLRQLQUDWVDVVHVVPHQWRIPR-
FDUGLDOSHUIXVLRQDQGSHUPHDELOLWDQGWKHUROHRIÁXLGUHVXV-
FLWDWLRQCrit Care Med
$NLUD68HPDWVX67DNHXFKL23DWKRJHQUHFRJQLWLRQDQGLQ-
QDWHLPPXQLWCell
.DNLKDQD,WR71DNDKDUD0DPDJXFKL.DVXGD76HSVLV
LQGXFHGPRFDUGLDOGVIXQFWLRQSDWKRSKVLRORJDQGPDQD-
JHPHQWJ Intensive Care
0HVTXLGD-*UXDUWPRQHU*)HUUHU53DVVLYHOHJUDLVLQJIRU
DVVHVVPHQWRIYROXPHUHVSRQVLYHQHVVDUHYLHZCurr Opin Crit
Care
*DUFtDGH$FLOX00HVTXLGD-*UXDUWPRQHU*)HUUHU5+H-
PRGQDPLFVXSSRUWLQVHSWLFVKRFNCurr Opin Anaesthesiol
'H%DFNHU''RQDGHOOR.6DNU2VSLQD7DVFRQ*6DOJDGR'
6FROOHWWD6HWDO0LFURFLUFXODWRUDOWHUDWLRQVLQSDWLHQWVZLWK
VHYHUHVHSVLVLPSDFWRIWLPHRIDVVHVVPHQWDQGUHODWLRQVKLS
ZLWKRXWFRPHCrit Care Med
5LYHUV(1JXHQ%+DYVWDG65HVVOHU-0X]]LQ$.QREOLFK%
HWDO(DUOJRDOGLUHFWHGWKHUDSLQWKHWUHDWPHQWRIVHYHUH
VHSVLVDQGVHSWLFVKRFNN Engl J Med
-XQJ)HUUDUL05|GLJHU)ULW]HQZDQJHU0*RHEHO%/DX-
WHQ$HWDO(YDOXDWLRQRIWKHVXEOLQJXDOPLFURFLUFXODWLRQLQ
FDUGLRJHQLFVKRFNClin Hemorheol Microcirc
'H%DFNHU'UHWHXU-'XERLV0-6DNU9LQFHQW-/0LFUR-
YDVFXODUDOWHUDWLRQVLQSDWLHQWVZLWKDFXWHVHYHUHKHDUWIDLOXUH
DQGFDUGLRJHQLFVKRFNAm Heart J
'XELQ$3R]R02)HUUDUD*0XULDV*0DUWLQV(DQXOOiQ
HWDO6VWHPLFDQGPLFURFLUFXODWRUUHVSRQVHVWRSURJUHVVLYH
KHPRUUKDJHIntensive Care Med
-KDQML6/HH:DWVRQ'+LQGV3HDUVH500LFURYDVFXODU
ÁRZDQGWLVVXHR[JHQDWLRQDIWHUPDMRUDEGRPLQDOVXUJHU
DVVRFLDWLRQZLWKSRVWRSHUDWLYHFRPSOLFDWLRQVIntensive Care
Med
'H%DFNHU''XERLV0-6FKPDUW]'.RFK0'XFDUW$%DUYDLV
/ HW DO 0LFURFLUFXODWRU DOWHUDWLRQV LQ FDUGLDF VXUJHU
HIIHFWVRIFDUGLRSXOPRQDUESDVVDQGDQHVWKHVLDAnn Thorac
Surg
(GXO96,QFH1DYDUUR13UHYLJOLDQR/5LVVR9D]TXH]$
5XEDWWR31HWDO'LVVRFLDWLRQEHWZHHQVXEOLQJXDODQGJXWPL-
FURFLUFXODWLRQLQWKHUHVSRQVHWRDÁXLGFKDOOHQJHLQSRVWRSH-
UDWLYHSDWLHQWVZLWKDEGRPLQDOVHSVLVAnn Intensive Care
6HFRU'/L)(OOLV*6KDUSH0'*URVV3/:LOVRQ-;HWDO
,PSDLUHGPLFURYDVFXODUSHUIXVLRQLQVHSVLVUHTXLUHVDFWLYDWHG
FRDJXODWLRQDQG3VHOHFWLQPHGLDWHGSODWHOHWDGKHVLRQLQFD-
SLOODULHVIntensive Care Med
0DVLS-0HVTXLGD-/XHQJR*LOL**RPj*)HUUHU5HWDO
1HDULQIUDUHGVSHFWURVFRS6W2PRQLWRULQJWRDVVHVVWKHWKH-
UDSHXWLFHIIHFWRIGURWUHFRJLQDOID DFWLYDWHG RQPLFURFLUFX-
ODWLRQLQSDWLHQWVZLWKVHYHUHVHSVLVRUVHSWLFVKRFNAnn In-
tensive Care
)DUTXKDU,0DUWLQ0/DP3RWWHU5(OOLV*6LEEDOG:-
'HFUHDVHGFDSLOODUGHQVLWLQYLYRLQERZHOPXFRVDRIUDWV
ZLWKQRUPRWHQVLYHVHSVLVJ Surg Res
7DFFRQH)66X)3LHUUDNRV+H;-DPHV6'HZLWWH2HWDO
HUHEUDOPLFURFLUFXODWLRQLVLPSDLUHGGXULQJVHSVLVDQH[SHUL-
PHQWDOVWXGCrit Care5
%DWHPDQ507RNXQDJD.DUHFR7'RUVFKHLG'5:DOOH.5
0RFDUGLDOKSR[LDLQGXFLEOH+,)DOSKD9(*)DQG*/87
JHQHH[SUHVVLRQLVDVVRFLDWHGZLWKPLFURYDVFXODUDQG,$0
KHWHURJHQHLWGXULQJHQGRWR[HPLDAm J Physiol Heart Circ
Physiol+
6DNU'XERLV0-'H%DFNHU'UHWHXU-9LQFHQW-/3HUVLV-
WHQWPLFURFLUFXODWRUDOWHUDWLRQVDUHDVVRFLDWHGZLWKRUJDQ
IDLOXUHDQGGHDWKLQSDWLHQWVZLWKVHSWLFVKRFNCrit Care Med
7U]HFLDN60FR-93KLOOLS'HOOLQJHU5$UQROG55L]]XWR0
$EDWH1/HWDO(DUOLQFUHDVHVLQPLFURFLUFXODWRUSHUIXVLRQ
GXULQJSURWRFROGLUHFWHGUHVXVFLWDWLRQDUHDVVRFLDWHGZLWKUH-
GXFHGPXOWLRUJDQIDLOXUHDWKLQSDWLHQWVZLWKVHSVLVIn-
tensive Care Med
'H%DFNHU'UHWHXU-3UHLVHU-'XERLV0-9LQFHQW-/0L-
FURYDVFXODUEORRGÁRZLVDOWHUHGLQSDWLHQWVZLWKVHSVLVAm J
Respir Crit Care Med
+XQJHUIRUG-(6HVVD:6HJDO669DVRPRWRUFRQWUROLQDUWH-
ULROHVRIWKHPRXVHFUHPDVWHUPXVFOHFASEB J
'LHWULFK++(OOVZRUWK0/6SUDJXH56'DFH5*-U5HGEORRGFHOO
UHJXODWLRQRIPLFURYDVFXODUWRQHWKURXJKDGHQRVLQHWULSKRVSKDWH
Am J Physiol Heart Circ Physiol++
- 13. Medicina Intensiva 46S1 (2022):1-13 13
7PO.:DQJ;/LGLQJWRQ'2XHOOHWWH/LSRSROVDFFKDULGH
UHGXFHVLQWHUFHOOXODUFRXSOLQJLQYLWURDQGDUWHULRODUFRQGXF-
WHG UHVSRQVH LQ YLYR Am J Physiol Heart Circ Physiol
++
'RHUVFKXJ.'HOVLQJ$66FKPLGW*$+DQHV:*,PSDLUPHQWV
LQPLFURYDVFXODUUHDFWLYLWDUHUHODWHGWRRUJDQIDLOXUHLQKXPDQ
VHSVLVAm J Physiol Heart Circ Physiol++
UHWHXU-DUROOR76ROGDWL*%XFKHOH*'H%DFNHU'9LQ-
FHQW-/7KHSURJQRVWLFYDOXHRIPXVFOH6W22 in septic pa-
WLHQWVIntensive Care Med
DEUDOHV39i]TXH]%7VDL$*,QWDJOLHWWD00LFURYDVFXODU
DQGFDSLOODUSHUIXVLRQIROORZLQJJOFRFDO[GHJUDGDWLRQJ
Appl Physiol (1985).
0DUHFKDO;)DYRU5-RXOLQ20RQWDLJQH'+DVVRXQ6'H-
FRVWHU%HWDO(QGRWKHOLDOJOFRFDO[GDPDJHGXULQJHQGR-
WR[HPLD FRLQFLGHV ZLWK PLFURFLUFXODWRU GVIXQFWLRQ DQG
YDVFXODUR[LGDWLYHVWUHVVShock
'H%DFNHU''RQDGHOOR.)DYRU5/LQNEHWZHHQFRDJXODWLRQ
DEQRUPDOLWLHVDQGPLFURFLUFXODWRUGVIXQFWLRQLQFULWLFDOOLOO
SDWLHQWVCurr Opin Anaesthesiol
3LDJQHUHOOL0%RXGMHOWLD.=9DQKDHYHUEHHN09LQFHQW-/
5HG EORRG FHOO UKHRORJ LQ VHSVLV Intensive Care Med
(LFKHOEU|QQHU26LHOHQNlPSHU$HSLQVNDV*6LEEDOG:-
KLQHH,+(QGRWR[LQSURPRWHVDGKHVLRQRIKXPDQHUWKUR-
FWHVWRKXPDQYDVFXODUHQGRWKHOLDOFHOOVXQGHUFRQGLWLRQVRI
ÁRZCrit Care Med.
,QFH+HPRGQDPLFFRKHUHQFHDQGWKHUDWLRQDOHIRUPRQLWR-
ULQJWKHPLFURFLUFXODWLRQCrit Care6XSSO6
5DG05LYHUV(3
1RZDN505HVXVFLWDWLRQRIWKHFULWLFDOOLOO
LQWKH('UHVSRQVHVRIEORRGSUHVVXUHKHDUWUDWHVKRFNLQ-
GH[FHQWUDOYHQRXVR[JHQVDWXUDWLRQDQGODFWDWHAm J
Emerg Med
9LQFHQW-/3ULYDOOH76LQJHU0/RUHQWH-$%RHKP(0HLHU
+HOOPDQQ$HWDO0XOWLFHQWHUUDQGRPL]HGSODFHERFRQWUROOHG
SKDVH,,,VWXGRISULGR[DODWHGKHPRJORELQSROR[HWKOHQHLQ
GLVWULEXWLYHVKRFN 3+2(1,; Crit Care Med
'XELQ$3R]R02DVDEHOOD$3iOL]DV)-U0XULDV*0RVHLQ-
FR0HWDO,QFUHDVLQJDUWHULDOEORRGSUHVVXUHZLWKQRUHSLQH-
SKULQHGRHVQRWLPSURYHPLFURFLUFXODWRUEORRGÁRZDSURV-
SHFWLYHVWXGCrit Care5
7RS$3,QFHGH0HLM1YDQ'LMN07LEERHO'3HUVLVWHQWORZ
PLFURFLUFXODWRUYHVVHOGHQVLWLQQRQVXUYLYRUVRIVHSVLVLQSH-
GLDWULFLQWHQVLYHFDUHCrit Care Med
%DWHPDQ50:DOOH.50LFURYDVFXODUUHVXVFLWDWLRQDVDWKHUD-
SHXWLFJRDOLQVHYHUHVHSVLVCrit Care6XSSO6
+DULUL*-RIIUH-/HEODQF*%RQVH0/DYLOOHJUDQG-58UELQD
7HWDO1DUUDWLYHUHYLHZFOLQLFDODVVHVVPHQWRISHULSKHUDOWLV-
VXHSHUIXVLRQLQVHSWLFVKRFNAnn Intensive Care
+HUQiQGH]*2VSLQD7DVFyQ*$'DPLDQL/3(VWHQVVRUR('X-
ELQ$+XUWDGR-HWDO(IIHFWRIDUHVXVFLWDWLRQVWUDWHJWDU-
JHWLQJSHULSKHUDOSHUIXVLRQVWDWXVYVVHUXPODFWDWHOHYHOVRQ
GDPRUWDOLWDPRQJSDWLHQWVZLWKVHSWLFVKRFN7KH$1-
'520('$6+2. UDQGRPL]HG FOLQLFDO WULDO JAMA
'QVHU0:7DNDOD-%UXQDXHU$%DNNHU-5HWKLQNLQJUHVXV-
FLWDWLRQOHDYLQJEORRGSUHVVXUHFRVPHWLFVEHKLQGDQGPRYLQJ
IRUZDUGWRSHUPLVVLYHKSRWHQVLRQDQGDWLVVXHSHUIXVLRQED-
VHGDSSURDFKCrit Care
*XWWHUPDQ''KDERZVNL'6.DGOHF$2'XUDQG0-)UHHG
-.$LW$LVVD.HWDO7KHKXPDQPLFURFLUFXODWLRQUHJXODWLRQ
RIÁRZDQGEHRQGCirc Res.
1DNDMLPD%DXGU1'XUDQWHDX-9LFDXW((IIHFWVRIYDVR-
SUHVVLQQRUHSLQHSKULQHDQG/DUJLQLQHRQLQWHVWLQDOPLFURFLU-
FXODWLRQLQHQGRWR[HPLDCrit Care Med
'H%DFNHU''RQDGHOOR.7DFFRQH)62VSLQD7DVFRQ*6DOJDGR
'9LQFHQW-/0LFURFLUFXODWRUDOWHUDWLRQVSRWHQWLDOPHFKDQLVPV
DQGLPSOLFDWLRQVIRUWKHUDSAnn Intensive Care
'pSUHW)6LWERQ$6RXVVL6'H7PRZVNL%OHW$)UDWDQL$
HWDO,QWUDYHQRXVLORSURVWWRUHFUXLWWKHPLFURFLUFXODWLRQLQ
VHSWLFVKRFNSDWLHQWVIntensive Care Med
-RKDQQHV7,QFH.OLQJHO.8QHUWO.(0LN(*,ORSURVWSUH-
VHUYHVUHQDOR[JHQDWLRQDQGUHVWRUHVNLGQHIXQFWLRQLQHQGR-
WR[HPLDUHODWHGDFXWHUHQDOIDLOXUHLQWKHUDWCrit Care Med
%RHUPD(.RRSPDQV0.RQLMQ$.DLIHURYD.%DNNHU$-YDQ
5RRQ(1HWDO(IIHFWVRIQLWURJOFHULQRQVXEOLQJXDOPLFURFLU-
FXODWRUEORRGÁRZLQSDWLHQWVZLWKVHYHUHVHSVLVVHSWLFVKRFN
DIWHUDVWULFWUHVXVFLWDWLRQSURWRFRODGRXEOHEOLQGUDQGRPL-
]HGSODFHERFRQWUROOHGWULDOCrit Care Med
*UXDUWPRQHU*0HVTXLGD-,QFH0LFURFLUFXODWRUPRQLWR-
ULQJLQVHSWLFSDWLHQWV:KHUHGRZHVWDQGMed Intensiva
'H%DFNHU'+ROOHQEHUJ6%RHUPD*RHGKDUW3%FKHOH*
2VSLQD7DVFRQ*HWDO+RZWRHYDOXDWHWKHPLFURFLUFXODWLRQ
UHSRUWRIDURXQGWDEOHFRQIHUHQFHCrit Care5
9DOHDQX/%XEHQHN7XUFRQL6,*LQJKLQD%DODQ+HPRGQD-
PLFMonitoring in Sepsis-A Conceptual Framework of Macro- and
Microcirculatory AlterationsDiagnostics (Basel)
%RQH56LU,VDDF1HZWRQVHSVLV6,56DQG$56Crit Care
Med.
/H7XO]R3DQJDXOW$PLRW/*XLOORX[97ULEXW2$UYLHX[
HWDO0RQRFWHKXPDQOHXNRFWHDQWLJHQ'5WUDQVFULSWLRQDO
GRZQUHJXODWLRQEFRUWLVROGXULQJVHSWLFVKRFNAm J Respir
Crit Care Med
DMDQGHU6%lFNPDQ$7LQD(6WUnOLQ.6|GHUTXLVW%.lOO-
PDQ-3UHOLPLQDUUHVXOWVLQTXDQWLWDWLRQRI+/$'5$EUHDO
WLPH35DSURPLVLQJDSSURDFKWRLGHQWLILPPXQRVXSSUHV-
VLRQLQVHSVLVCrit Care5
D]DOLV0$)ULJJHUL$DYp/'HPDUHW-%DUEDODW9HUUDWR
(HWDO'HFUHDVHG+/$'5DQWLJHQDVVRFLDWHGLQYDULDQWFKDLQ
' P51$H[SUHVVLRQSUHGLFWVPRUWDOLWDIWHUVHSWLFVKRFN
Crit Care5
6SLQHWWL7+LU]HO)X[0:DOWL/16FKREHU36WXHEHU)HW
DO5HGXFHGPRQRFWLFKXPDQOHXNRFWHDQWLJHQ'5H[SUHV-
VLRQLQGLFDWHVLPPXQRVXSSUHVVLRQLQFULWLFDOOLOO29,'SD-
WLHQWVAnesth Analg
7VFKDLNRZVN.+HGZLJ*HLVVLQJ06FKLHOH$%UHPHU)
6FKZDOVN06FKWWOHU-RLQFLGHQFHRISURDQGDQWLLQ-
ÁDPPDWRUUHVSRQVHVLQWKHHDUOSKDVHRIVHYHUHVHSVLV/RQ-
JLWXGLQDOVWXGRIPRQRQXFOHDUKLVWRFRPSDWLELOLWOHXNRFWH
DQWLJHQ'5H[SUHVVLRQSURFDOFLWRQLQUHDFWLYHSURWHLQDQG
FKDQJHVLQ7FHOOVXEVHWVLQVHSWLFDQGSRVWRSHUDWLYHSDWLHQWV
Crit Care Med
'|FNH:'5DQGRZ)6UEH8.UDXVFK'$VDGXOODK.5HLQNH
3HWDO0RQRFWHGHDFWLYDWLRQLQVHSWLFSDWLHQWVUHVWRUDWLRQ
E,)1JDPPDWUHDWPHQWNat Med
0HLVHO6FKHIROG-3VFKRZVNL5%DXPDQQ7+HW]JHU.
*UHJRU-HWDO*UDQXORFWHPDFURSKDJHFRORQVWLPXODWLQJ
IDFWRUWRUHYHUVHVHSVLVDVVRFLDWHGLPPXQRVXSSUHVVLRQDGRX-
EOHEOLQGUDQGRPL]HGSODFHERFRQWUROOHGPXOWLFHQWHUWULDO
Am J Respir Crit Care Med
$JDWD.DZDVDNL$1LVKLPXUD+,VKLGD7VXEDWD7DJLWD+
HWDO([SUHVVLRQRIWKH3'DQWLJHQRQWKHVXUIDFHRIVWLPXOD-
WHGPRXVH7DQG%OPSKRFWHVInt Immunol
6KDUSH$+:KHUU(-$KPHG5)UHHPDQ*-7KHIXQFWLRQRI
SURJUDPPHGFHOOGHDWKDQGLWVOLJDQGVLQUHJXODWLQJDXWRLP-
PXQLWDQGLQIHFWLRQNat Immunol
=KDQJ/L-/RX-=KRX%R/=KX-HWDO8SUHJXODWLRQRI
SURJUDPPHGGHDWKRQ7FHOOVDQGSURJUDPPHGGHDWKOLJDQG
RQPRQRFWHVLQVHSWLFVKRFNSDWLHQWVCrit Care5
3DWHUD$'UHZU$0KDQJ.%HLWHU(52VERUQH'+RWFK-
NLVV56)URQWOLQHVFLHQFHGHIHFWVLQLPPXQHIXQFWLRQLQSD-
WLHQWVZLWKVHSVLVDUHDVVRFLDWHGZLWK3'RU3'/H[SUHVVLRQ
DQGFDQEHUHVWRUHGEDQWLERGLHVWDUJHWLQJ3'RU3'/J
Leukoc Biol
![0210-5691/ © 2022 Elsevier España, S.L.U. y SEMICYUC. Todos los derechos reservados.
medicina intensiva
www.medintensiva.org
Medicina Intensiva 46S1 (2022):1-13
https://doi.org/ 10.1016/j.medin.2022.03.017
Volumen 34, Número 5. Junio-Julio 2010
Sociedad Española
de Medicina Intensiva, Crítica
y Unidades Coronarias
Federación Panamericana
e Ibérica de Sociedades
de Medicina Crítica
y Terapia Intensiva
www.elsevier.es/medintensiva
www.semicyuc.org
www.fepimcti.org
Incluida en:
Index Medicus/MEDLINE
EMBASE/Excerpta Medica
SCOPUS
ISSN:
0210-5691
Editorial
Diagnóstico precoz del fracaso renal agudo
M. Rodríguez López y A. Roglan Piqueras
291
Originales
Concordancia en pacientes críticos entre las
ecuaciones diseñadas para la estimación
del filtrado glomerular y el aclaramiento de
creatinina en orina de 24h
G. Seller-Pérez, M.E. Herrera-Gutiérrez,
E. Banderas-Bravo, R. Olalla-Sánchez,
R. Lozano-Sáez y G. Quesada-García
294
Sincronía auriculo-ventricular en pacientes
portadores de marcapasos con estimulación
VDD. Estudio descriptivo de un periodo de
14 años
A. Canabal Berlanga, M. Sánchez Casado,
J.M. Díaz Borrego, A. Raigal Caño y
P. Sánchez Rodríguez
303
Síndrome de Distrés Respiratorio Agudo,
durante la pandemia de Influenza A H1N1
2009 en Ecuador
G. Paredes y C. Cevallos
310
Puesta al día: El enfermo crítico con
infección grave
Neumonía asociada a la ventilación
mecánica
E. Diaz, L. Lorente, J. Valles y J. Rello
318
Debates en Medicina Intensiva:
Empleo de Descontaminación
Digestiva Selectiva
Pro descontaminación selectiva
M. Sánchez García
325
Descontaminación: un tratamiento sin
indicaciones
E. Palencia Herrejón y P. Rico Cepeda
334
Revisión
Hemofiltración de alto volumen en shock
séptico
C.M. Romero, P. Downey y G. Hernández
345
Nota clínica
Hiperinfección por Strongyloides stercoralis
J. Llagunes, E. Mateo, J.J. Peña, P. Carmona y
J. de Andrés
353
Cartas al Director
Administración accidental de dosis tóxicas
de adrenalina intravenosa a un lactante de
5 meses
M.S. Holanda Peña, J.L. Teja Barbero,
J. Velasco Montes y M. López Sánchez
357
Diagnóstico tardío de un caso de porfiria
aguda intermitente en una unidad de
cuidados intensivos
A.J. Betbesé, L. Zapata, C. Martínez-Brú y
C. Herrero
358
Muerte encefálica aparente tras sobredosis
de baclofén
R. Salas De Zayas, F. San José Pacheco,
C. Dolera Moreno y L. Zoila Peiró
359
Imágenes en Medicina Intensiva
Embolia aérea pulmonar como complicación
de punción venosa central
J. Bayón, M. Martín e I. Lozano
360
Actividad acreditada
en base a la encomienda de gestión concedida por los Ministerios
de Educación, Cultura y Deporte y de Sanidad y Consumo
ciales de Médicos con
2,1 créditos equivalentes a 10 horas lectivas.
www.formacion.elsevier.es/medicinaintensiva
COMISIÓN
DE FORMACIÓN
CONTINUADA DEL SNS
PALABRAS CLAVE
Sepsis;
Shock séptico;
Respuesta
LQÁDPDWRULD
Citocina;
Endotelio;
Endotoxina;
0LFURFLUFXODFLyQ
Resumen La sepsis y el shockVpSWLFRVRQHOUHVXOWDGRGHXQDUHVSXHVWDLQDGHFXDGDGHOKXpVSHG
DXQDLQIHFFLyQORTXHSURGXFHGLVIXQFLyQRUJiQLFD/DSURJUHVLyQGHHVWDDIHFFLyQVHPDQLÀHVWD
SRUODDSDULFLyQGHHVWDGLRVFOtQLFRVVXFHVLYRVGHULYDGRVGHODUHVSXHVWDLQÁDPDWRULDVLVWpPLFD
VHFXQGDULDDODDFWLYDFLyQGHGLIHUHQWHVPHGLDGRUHVLQÁDPDWRULRVTXHFRQGXFHQDODGLVIXQFLyQ
RUJiQLFD+DJUDQFDQWLGDGGHHYLGHQFLDVREUHHOSDSHOGHODHQGRWR[LQDHQODSDWRJpQHVLVGHOD
VHSVLVHOSDSHOIXQGDPHQWDOTXHWLHQHHQHOLQLFLRGHODUHVSXHVWDLQÁDPDWRULDHQODVHSVLVFDX-
VDGDSRUPLFURRUJDQLVPRV*UDPQHJDWLYRV/DDFWLYDFLyQGHODFDVFDGDGHFRDJXODFLyQHQORVSD-
FLHQWHVFRQVHSVLVHVSDUWHGHODUHVSXHVWDLQPXQLWDULDDGDSWDWLYDGHOKXpVSHGDODLQIHFFLyQ(O
HQGRWHOLRHVHOEODQFRSULQFLSDOHQODVHSVLVHOFXDOHVPHWDEyOLFDPHQWHDFWLYRSXHGHUHVSRQGHU
DGLYHUVRVHVWtPXORVÀVLROyJLFRVSDWROyJLFRV DFWLYDFLyQHQGRWHOLDO $GDSWDUORVWUDWDPLHQWRVD
SDFLHQWHVHVSHFtÀFRVHVXQDHVWUDWHJLDREOLJDGDSHUVRQDOL]DGDSDUDFHQWUDUVHHQODFRKHUHQFLD
KHPRGLQiPLFD/DLQYHVWLJDFLyQIXWXUDGHEHUHVSRQGHUDVLODVHVWUDWHJLDVGLULJLGDVDUHFOXWDU
PLFURFLUFXODFLyQSXHGHQPHMRUDUORVGHVHQODFHVFOtQLFRVGHORVSDFLHQWHV
‹(OVHYLHU(VSDxD6/86(0,87RGRVORVGHUHFKRVUHVHUYDGRV
Pathophysiology of septic shock
Abstract 6HSVLVDQGVHSWLFVKRFNUHVXOWIURPDQLQDGHTXDWHKRVWUHVSRQVHWRDQLQIHFWLRQ
ZKLFKFDXVHVRUJDQGVIXQFWLRQ7KHSURJUHVVLRQRIWKLVFRQGLWLRQLVPDQLIHVWHGEWKHRFFX-
UUHQFHRIVXFFHVVLYHFOLQLFDOVWDJHVUHVXOWLQJIURPWKHVVWHPLFLQÁDPPDWRUUHVSRQVHVHFRQ-
GDUWRWKHDFWLYDWLRQRIGLIIHUHQWLQÁDPPDWRUPHGLDWRUVOHDGLQJWRRUJDQGVIXQFWLRQ7KHUH
LVDKLJKEXUGHQRIHYLGHQFHRQWKHUROHRIHQGRWR[LQLQWKHSDWKRJHQHVLVRIVHSVLVDQGLWVFUXFLDO
UROHLQWULJJHULQJWKHLQÁDPPDWRUUHVSRQVHLQVHSVLVFDXVHGEJUDPQHJDWLYHEDFWHULD7KH
FRDJXODWLRQFDVFDGHDFWLYDWLRQLQVHSVLVSDWLHQWVLVSDUWRIWKHKRVW·VDGDSWLYHLPPXQHUHVSRQVH
WRLQIHFWLRQ7KHHQGRWKHOLXPLVWKHPDLQWDUJHWLQVHSVLVZKLFKLVPHWDEROLFDOODFWLYHDQGFDQ
$XWRUSDUDFRUUHVSRQGHQFLD
Correo electrónico:UIHUUHU#YKHEURQQHW 5)HUUHU
5(68,7$,Ð1'(/3$,(17(216(36,6SHOCK6e37,2
Fisiopatología del shock séptico
Luis Chiscano-Camóna,b,c
, Erika Plata-Menchacaa,b
, Juan Carlos Ruiz-Rodrígueza,b,c
y Ricard Ferrera,b,c,
*
a
Servicio de Medicina Intensiva, Hospital Universitario Vall d’Hebron, Barcelona, España
b
Grupo de Investigación Sepsis Organ Dysfunction and Resuscitation (SODIR), Vall d’Hebron Institut de Recerca (VHIR),
Hospital Universitari Vall d’Hebron, Barcelona, España
c
Departament de Medicina. Universitat Autònoma de Barcelona. Barcelona. España
KEYWORDS
Sepsis;
6HSWLFVKRFN
,QÁDPPDWRU
UHVSRQVH
WRNLQH
(QGRWKHOLXP
Endotoxin;
0LFURFLUFXODWLRQ](https://image.slidesharecdn.com/s02105691220010973-230427102705-94bf956d/85/S0210569122001097-3-pdf-1-320.jpg)
![/KLVFDQR(3ODWD0HQFKDFD-5XL]5RGUtJXH]HWDO
UHVSRQGWRYDULRXVSKVLRORJLFDODQGSDWKRORJLFDOVWLPXOL$GDSWLQJWUHDWPHQWVWRVSHFLÀFSD-
WLHQWVZLOOEHDPDQGDWRUDQGSHUVRQDOL]HGVWUDWHJWRIRFXVRQ´KHPRGQDPLFFRKHUHQFHµ
)XWXUHUHVHDUFKVKRXOGDQVZHUZKHWKHUVWUDWHJLHVWRUHFUXLWPLFURFLUFXODWLRQFDQLPSURYHFOLQL-
FDORXWFRPHV
‹(OVHYLHU(VSDxD6/86(0,8$OOULJKWVUHVHUYHG
Introducción
La sepsis y el shockVpSWLFRVRQHOUHVXOWDGRGHODUHVSXHVWD
LQDGHFXDGDGHOKXpVSHGDXQDLQIHFFLyQTXHRFDVLRQDGLV-
IXQFLyQGHXQRRPiVyUJDQRV1
/DUHVSXHVWDLQÁDPDWRULDHQ
ODPDRUtDGHORVLQGLYLGXRVHVDGDSWDWLYDFRQWULEXHD
FRQWURODUODLQIHFFLyQ6LQHPEDUJRHQODVHSVLVVHSURGXFH
XQGHVHTXLOLEULRHQWUHORVPHFDQLVPRVSURLQÁDPDWRULRV
DQWLLQÁDPDWRULRV/DSURJUHVLyQGHHVWDFRQGLFLyQVHFDUDF-
WHUL]DSRUODDSDULFLyQVXFHVLYDGHHVWDGLRVFOtQLFRVTXHVRQ
HOUHVXOWDGRGHODUHVSXHVWDLQÁDPDWRULDVLVWpPLFDVHFXQGD-
ULDDODDFWLYDFLyQGHGLIHUHQWHVPHGLDGRUHVLQÁDPDWRULRV
TXHFRQGXFHQDGLVIXQFLyQRUJiQLFD2
(ÀJXUD (VWRLQFOXH
GLIHUHQWHVSURFHVRVÀVLROyJLFRVFRPRODDFWLYDFLyQGHGLIH-
UHQWHVOtQHDVFHOXODUHV PRQRFLWRVPDFUyIDJRVQHXWUyÀORV
FpOXODVHQGRWHOLDOHVSODTXHWDV ODSURGXFFLyQORFDOVLVWp-
PLFDGHFLWRFLQDVODHVWLPXODFLyQGHODFDVFDGDGHSURWHt-
QDVSODVPiWLFDV FRPRHOVLVWHPDGHOFRPSOHPHQWR OD
DFWLYDFLyQGHODVYtDVGHFRDJXODFLyQLQWUtQVHFD VLVWHPDGH
FRQWDFWR H[WUtQVHFDHOVLVWHPDÀEULQROtWLFRODSURGXF-
FLyQGHPHGLDGRUHVOLStGLFRVODDFWLYDFLyQGHODYtDGHO
y[LGRQtWULFR 12 ODSURGXFFLyQGHUDGLFDOHVOLEUHVODHVWL-
PXODFLyQGHORVOLQIRFLWRV%7VXVSURGXFWRVIHQyPHQRV
GHSURWHROLVLV3
HQWUHRWURV4
Figura 1 (YROXFLyQGHODVHSVLVRQODLQWHUDFFLyQGH3$03'$03FRQODFpOXODSUHVHQWDGRUDGHDQWtJHQRVVHLQLFLDODFDVFDGD
LQÁDPDWRULDGHODLQPXQLGDGLQQDWDDGDSWDWLYD/DLQÁDPDFLyQFDXVDGDxRWLVXODUVHFXQGDULDPHQWHGLVIXQFLyQRUJiQLFD(Q
DOJXQRVSDFLHQWHVVHJHQHUDXQHVWDGRGHLQPXQRSDUiOLVLVFDUDFWHUL]DGRSRUODDSDULFLyQGHLQIHFFLRQHVQRVRFRPLDOHVRSRUWXQLVWDV
UHDFWLYDFLRQHVYLUDOHVGHELGRDODDSRSWRVLVGHOWHMLGRLQPXQLWDULRODLQFDSDFLGDGUHODWLYDGHODVFpOXODV7 '$03 damage-
associated molecular patterns; 3$03pathogen-derived molecular patterns; 7/5 toll-like receptor.](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)